-- https://www.phpmyadmin.net/
--

START TRANSACTION;



--
-- Database: `agex_11_11_2021`
--

-- --------------------------------------------------------

--
-- Table structure for table `client_logo`
--

CREATE TABLE `client_logo` (
  `client_logo_id` int(11) NOT NULL,
  `logo_image_name` varchar(300) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `client_logo`
--

INSERT INTO `client_logo` (`client_logo_id`, `logo_image_name`) VALUES
(46, '1636620204_one.png'),
(47, '1636620212_two.png'),
(48, '1636620223_three.png'),
(49, '1636620242_four.png'),
(50, '1636620250_five.png'),
(51, '1636620258_six.png');

-- --------------------------------------------------------

--
-- Table structure for table `coins_cate`
--

CREATE TABLE `coins_cate` (
  `cat_id` int(11) NOT NULL,
  `cate_name` varchar(200) NOT NULL,
  `category_image` varchar(200) NOT NULL,
  `cate_desc` text NOT NULL,
  `stastus` varchar(50) NOT NULL,
  `home_status` varchar(11) NOT NULL,
  `dat` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `coins_cate`
--

INSERT INTO `coins_cate` (`cat_id`, `cate_name`, `category_image`, `cate_desc`, `stastus`, `home_status`, `dat`) VALUES
(1, 'Gold', '20064.', '', '', '', '2019-07-29 07:10:55'),
(2, 'Silver', '20249.', '', '', '', '2019-07-29 07:12:45');

-- --------------------------------------------------------

--
-- Table structure for table `coins_product`
--

CREATE TABLE `coins_product` (
  `pro_id` int(11) NOT NULL,
  `pid` varchar(255) NOT NULL,
  `pro_moq` varchar(255) NOT NULL,
  `pro_name` varchar(255) NOT NULL,
  `new` varchar(5) NOT NULL,
  `sale` varchar(5) NOT NULL,
  `pro_price` float NOT NULL,
  `pro_discount` int(11) NOT NULL,
  `pro_code` varchar(200) NOT NULL,
  `discount` varchar(100) NOT NULL,
  `pro_quan` int(11) NOT NULL DEFAULT '0',
  `shopbyprice` int(11) NOT NULL,
  `shopbymoq` int(11) NOT NULL,
  `pro_scheme` varchar(255) NOT NULL,
  `pro_weight` varchar(255) NOT NULL,
  `pro_desc` text NOT NULL,
  `pro_specification` text NOT NULL,
  `pro_detail` text NOT NULL,
  `pro_image` varchar(255) NOT NULL,
  `pro_image1` varchar(255) NOT NULL,
  `ebra_name` varchar(255) NOT NULL,
  `status` varchar(100) NOT NULL,
  `unit` varchar(200) NOT NULL,
  `moq_status` varchar(100) NOT NULL,
  `pro_date` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP,
  `pro_title` text NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

-- --------------------------------------------------------

--
-- Table structure for table `collection_metal_information`
--

CREATE TABLE `collection_metal_information` (
  `id` int(11) NOT NULL,
  `list_id` int(11) NOT NULL,
  `title1` varchar(400) NOT NULL,
  `desc1` varchar(400) NOT NULL,
  `title2` varchar(400) NOT NULL,
  `desc2` varchar(400) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `collection_metal_information`
--

INSERT INTO `collection_metal_information` (`id`, `list_id`, `title1`, `desc1`, `title2`, `desc2`) VALUES
(1, 1, ' Metal', 'Gold', 'Metal Weight (Approx)', '1.3 g'),
(2, 1, 'Metal Purity', '22KT', 'Metal Certification', 'BIS Hallmark'),
(4, 2, 'Vision', '', '', '');

-- --------------------------------------------------------

--
-- Table structure for table `collection_product_information`
--

CREATE TABLE `collection_product_information` (
  `id` int(11) NOT NULL,
  `list_id` int(11) NOT NULL,
  `title1` varchar(400) NOT NULL,
  `desc1` varchar(400) NOT NULL,
  `title2` varchar(400) NOT NULL,
  `desc2` varchar(400) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `collection_product_information`
--

INSERT INTO `collection_product_information` (`id`, `list_id`, `title1`, `desc1`, `title2`, `desc2`) VALUES
(1, 1, 'Design Number', '327002', 'Width (mm)', '20.72'),
(2, 1, 'Design Code', 'ZLR00323', 'Height (mm)', '23.38');

-- --------------------------------------------------------

--
-- Table structure for table `gemstone_cate`
--

CREATE TABLE `gemstone_cate` (
  `cat_id` int(11) NOT NULL,
  `cate_name` varchar(200) NOT NULL,
  `category_image` varchar(200) NOT NULL,
  `cate_desc` text NOT NULL,
  `stastus` varchar(50) NOT NULL,
  `home_status` varchar(11) NOT NULL,
  `dat` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `gemstone_cate`
--

INSERT INTO `gemstone_cate` (`cat_id`, `cate_name`, `category_image`, `cate_desc`, `stastus`, `home_status`, `dat`) VALUES
(3, 'dfg', '16856.', '', '', '', '2021-11-11 12:03:03');

-- --------------------------------------------------------

--
-- Table structure for table `gemstone_metal_information`
--

CREATE TABLE `gemstone_metal_information` (
  `id` int(11) NOT NULL,
  `list_id` int(11) NOT NULL,
  `title1` varchar(400) NOT NULL,
  `desc1` varchar(400) NOT NULL,
  `title2` varchar(400) NOT NULL,
  `desc2` varchar(400) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `gemstone_metal_information`
--

INSERT INTO `gemstone_metal_information` (`id`, `list_id`, `title1`, `desc1`, `title2`, `desc2`) VALUES
(1, 1, ' Metal', 'Gold', 'Metal Weight (Approx)', '1.3 g'),
(2, 1, 'Metal Purity', '22KT', 'Metal Certification', 'BIS Hallmark'),
(4, 2, 'Vision', '', '', '');

-- --------------------------------------------------------

--
-- Table structure for table `gemstone_product`
--

CREATE TABLE `gemstone_product` (
  `pro_id` int(11) NOT NULL,
  `pid` varchar(255) NOT NULL,
  `pro_moq` varchar(255) NOT NULL,
  `pro_name` varchar(255) NOT NULL,
  `new` varchar(5) NOT NULL,
  `sale` varchar(5) NOT NULL,
  `pro_price` float NOT NULL,
  `pro_discount` int(11) NOT NULL,
  `pro_code` varchar(200) NOT NULL,
  `discount` varchar(100) NOT NULL,
  `pro_quan` int(11) NOT NULL DEFAULT '0',
  `shopbyprice` int(11) NOT NULL,
  `shopbymoq` int(11) NOT NULL,
  `pro_scheme` varchar(255) NOT NULL,
  `pro_weight` varchar(255) NOT NULL,
  `pro_desc` text NOT NULL,
  `pro_specification` text NOT NULL,
  `pro_detail` text NOT NULL,
  `pro_image` varchar(255) NOT NULL,
  `pro_image1` varchar(255) NOT NULL,
  `ebra_name` varchar(255) NOT NULL,
  `status` varchar(100) NOT NULL,
  `unit` varchar(200) NOT NULL,
  `moq_status` varchar(100) NOT NULL,
  `pro_date` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP,
  `pro_title` text NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

-- --------------------------------------------------------

--
-- Table structure for table `gemstone_product_information`
--

CREATE TABLE `gemstone_product_information` (
  `id` int(11) NOT NULL,
  `list_id` int(11) NOT NULL,
  `title1` varchar(400) NOT NULL,
  `desc1` varchar(400) NOT NULL,
  `title2` varchar(400) NOT NULL,
  `desc2` varchar(400) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `gemstone_product_information`
--

INSERT INTO `gemstone_product_information` (`id`, `list_id`, `title1`, `desc1`, `title2`, `desc2`) VALUES
(1, 1, ' Metal', 'Gold', 'Metal Weight (Approx)', '1.3 g'),
(2, 1, 'Metal Purity', '22KT', 'Metal Certification', 'BIS Hallmark'),
(4, 2, 'Vision', '', '', '');

-- --------------------------------------------------------

--
-- Table structure for table `gemstone_subcate`
--

CREATE TABLE `gemstone_subcate` (
  `id` int(100) NOT NULL,
  `cat_id` int(100) NOT NULL,
  `sub_name` varchar(200) NOT NULL,
  `sub_image` text NOT NULL,
  `stastus` varchar(50) NOT NULL,
  `home_status` varchar(11) NOT NULL,
  `dat` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `gemstone_subcate`
--

INSERT INTO `gemstone_subcate` (`id`, `cat_id`, `sub_name`, `sub_image`, `stastus`, `home_status`, `dat`) VALUES
(15, 3, 'Rings', '14154.', '', '', '2019-07-27 11:27:06'),
(16, 3, 'Earrings', '18107.', '', '', '2019-07-27 11:27:14'),
(17, 3, 'Pendant', '6424.', '', '', '2019-07-27 11:27:21'),
(18, 3, 'Chains', '12145.', '', '', '2019-07-27 11:27:28'),
(19, 3, 'Nose Pins', '20822.', '', '', '2019-07-27 11:27:38'),
(20, 3, 'Mangalsutra', '2715.', '', '', '2019-07-27 11:41:07');

-- --------------------------------------------------------

--
-- Table structure for table `header_flash`
--

CREATE TABLE `header_flash` (
  `header_id` int(11) NOT NULL,
  `header_image_name` varchar(300) NOT NULL,
  `offer_title` varchar(300) NOT NULL,
  `title` varchar(400) NOT NULL,
  `title_desc` varchar(500) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `header_flash`
--

INSERT INTO `header_flash` (`header_id`, `header_image_name`, `offer_title`, `title`, `title_desc`) VALUES
(46, '1635857793_1564228096_slider-30.jpg', 'Your health matters', 'Good Medicine For Good Health', 'We are committed to increasing the longevity of individuals and enabling them to live healthy and better life.'),
(52, '1635858340_1564228096_slider-31.jpg', 'Your health is our concern', 'Committed to Quality and Safety', 'At Agex, our emphasis on quality, innovation, and affordable solutions in medicine makes us one of the significant players in the Indian pharmaceutical market. '),
(57, '1635858798_1564228096_slider-32.jpg', 'Healthcare Made Easy', ' Fastest Growing Pharmaceutical', 'Our prime focus is no on delivering affordable and accessible medicines to meet community needs. ');

-- --------------------------------------------------------

--
-- Table structure for table `profmonth`
--

CREATE TABLE `profmonth` (
  `id` int(11) NOT NULL,
  `pro_name` varchar(255) NOT NULL,
  `pro_title` varchar(255) NOT NULL,
  `image` varchar(100) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `profmonth`
--

INSERT INTO `profmonth` (`id`, `pro_name`, `pro_title`, `image`) VALUES
(11, 'Product of the Month', '', '1635855820_2.jpg'),
(13, 'Product of the Month', '', '1635855827_1.jpg'),
(14, 'Product of the Month', '', '1635855834_3.jpg');

-- --------------------------------------------------------

--
-- Table structure for table `profweek`
--

CREATE TABLE `profweek` (
  `id` int(11) NOT NULL,
  `pro_name` varchar(255) NOT NULL,
  `pro_title` varchar(255) NOT NULL,
  `image` varchar(100) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `profweek`
--

INSERT INTO `profweek` (`id`, `pro_name`, `pro_title`, `image`) VALUES
(7, 'Product of the Week', '', '1557987295_banner5-420x270.png'),
(8, 'Product of the Week', '', '1557987205_banner5-420x270.png'),
(10, 'Product of the Week', '', '1557987210_banner5-420x270.png');

-- --------------------------------------------------------

--
-- Table structure for table `shopbymoq`
--

CREATE TABLE `shopbymoq` (
  `id` int(11) NOT NULL,
  `shop_moq` varchar(200) NOT NULL,
  `datess` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `shopbymoq`
--

INSERT INTO `shopbymoq` (`id`, `shop_moq`, `datess`) VALUES
(1, '50 To 100 Pc.', '2019-05-14 09:56:51'),
(2, ' 101 To 150 Pc.', '2019-05-14 09:57:07'),
(3, '151 To 200 Pc.', '2019-05-14 09:57:18'),
(4, ' 201 To 250 Pc.', '2019-05-14 10:06:46'),
(5, ' 251 To 300 Pc.', '2019-05-14 10:06:51'),
(6, ' 301 To 350 Pc.', '2019-05-14 10:06:57'),
(7, ' 351 To 400 Pc.', '2019-05-14 10:07:02');

-- --------------------------------------------------------

--
-- Table structure for table `shopbyprice`
--

CREATE TABLE `shopbyprice` (
  `id` int(11) NOT NULL,
  `shop_price` varchar(200) NOT NULL,
  `datess` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `shopbyprice`
--

INSERT INTO `shopbyprice` (`id`, `shop_price`, `datess`) VALUES
(1, '  1 To 50', '0000-00-00 00:00:00'),
(2, ' 51 To 100', '2019-05-14 09:17:51'),
(5, '101 To 150', '2019-05-14 09:43:34'),
(6, ' 201 To 250', '2019-05-14 10:06:01'),
(7, '  251 To 300', '2019-05-14 10:06:09'),
(8, ' 301 To 350', '2019-05-14 10:06:15'),
(9, ' 351 To 400', '2019-05-14 10:06:22');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_about_home`
--

CREATE TABLE `tbl_about_home` (
  `id` int(11) NOT NULL,
  `about_desc` text NOT NULL,
  `about_desc1` text NOT NULL,
  `about_desc3` text NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_about_home`
--

INSERT INTO `tbl_about_home` (`id`, `about_desc`, `about_desc1`, `about_desc3`) VALUES
(1, '<h3><span style=\"color:#3498db\">Matson Surgicals Was Established In The Year 1986 But Was Later Incorporated Into Pvt. Ltd. Company In The Year 2004</span>.</h3>\r\n\r\n<p>We are introducing ourselves as a reputed Distributers &amp; importer for various types of life saving consumables items, in the field of Anaesthesiology, Radiology, Urology, Critical Care, Nephrology, Cardiology, Distributers &amp; importer for various types of life saving consumables items, in the field of Anaesthesiology, Radiology, Urology, Critical Care, Nephrology, Cardiology, CTVS ETC.</p>\r\n', '', '');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_about_us`
--

CREATE TABLE `tbl_about_us` (
  `id` int(11) NOT NULL,
  `title_about1` varchar(255) NOT NULL,
  `title_about2` varchar(255) NOT NULL,
  `title_about3` varchar(255) NOT NULL,
  `desc_about1` varchar(500) NOT NULL,
  `desc_about2` varchar(500) NOT NULL,
  `desc_about3` varchar(500) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_about_us`
--

INSERT INTO `tbl_about_us` (`id`, `title_about1`, `title_about2`, `title_about3`, `desc_about1`, `desc_about2`, `desc_about3`) VALUES
(1, 'RELIABLE COMPANY', 'HIGH QUALITY STANDARTS', '100% CUSTOMERS SUPPORT', 'Over the years we have expanded beyond the boundaries of Delhi and have become a truly multi-product, multi-location company serving various industries across India & Abroad.', 'We will take the advanced management and the idea of daring to innovate as the core power of our company, and will provide high quality, practical, reliable pipe fittings and flanges to our users.', 'From the very first stage of procurement of raw materials to the final dispatch, our products are timely altered according to ASTM requirements, assuring international quality standards. We assure you of our best Quality and Services.');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_add_list`
--

CREATE TABLE `tbl_add_list` (
  `id` int(11) NOT NULL,
  `list_id` int(11) NOT NULL,
  `title1` varchar(400) NOT NULL,
  `desc1` varchar(400) NOT NULL,
  `title2` varchar(400) NOT NULL,
  `desc2` varchar(400) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_add_list`
--

INSERT INTO `tbl_add_list` (`id`, `list_id`, `title1`, `desc1`, `title2`, `desc2`) VALUES
(1, 1, ' Metal', 'Gold', 'Metal Weight (Approx)', '1.3 g'),
(2, 1, 'Metal Purity', '22KT', 'Metal Certification', 'BIS Hallmark');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_banner`
--

CREATE TABLE `tbl_banner` (
  `banner_id` int(11) NOT NULL,
  `banner_image_name` varchar(200) NOT NULL,
  `banner_link` varchar(200) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_banner`
--

INSERT INTO `tbl_banner` (`banner_id`, `banner_image_name`, `banner_link`) VALUES
(13, '1497099873_banner1.jpg', 'http://fiberation.com/'),
(24, '1497099974_banner2.jpg', 'http://babyjhula.in/');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_blog`
--

CREATE TABLE `tbl_blog` (
  `id` int(11) NOT NULL,
  `b_name` varchar(250) NOT NULL,
  `Briefing` text NOT NULL,
  `a_name` varchar(150) NOT NULL,
  `b_folder` varchar(250) NOT NULL,
  `b_desc` text NOT NULL,
  `b_image` varchar(200) NOT NULL,
  `b_date` datetime NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_blog`
--

INSERT INTO `tbl_blog` (`id`, `b_name`, `Briefing`, `a_name`, `b_folder`, `b_desc`, `b_image`, `b_date`) VALUES
(3, 'Beware the unintendented consequences of a win-win-win', 'Well Happy New Year all! I guess you could say Pharmacist Jamie was on a bit of a break. Enjoying a little family time.', 'Jason Poquette', 'blog', '<p>Well Happy New Year all! I guess you could say Pharmacist Jamie was on a bit of a break. Enjoying a little family time during the holidays and keeping up with my day job has consumed the past few months. So I thought why not kick off 2016 with a controversial topic!</p>\r\n\r\n<p>The weekly Wednesday #RxChat got the ole wheels turning today. We were discussing new regulations and laws in our states and how they will effect our current practice. The chat quickly turned to the dispensing of birth control pills without a prescription. Looks like Oregon and California are allowing pharmacists to dispense these hormonal contraceptives without a valid prescription.</p>\r\n', '1637123006_one.jpg', '2021-11-17 10:00:48'),
(4, 'Beware the unintendented consequences of a win-win-win', 'Well Happy New Year all! I guess you could say Pharmacist Jamie was on a bit of a break. Enjoying a little family time.', ' Jason Poquette', 'Blog', '<p>Well Happy New Year all! I guess you could say Pharmacist Jamie was on a bit of a break. Enjoying a little family time during the holidays and keeping up with my day job has consumed the past few months. So I thought why not kick off 2016 with a controversial topic!</p>\r\n\r\n<p>The weekly Wednesday #RxChat got the ole wheels turning today. We were discussing new regulations and laws in our states and how they will effect our current practice. The chat quickly turned to the dispensing of birth control pills without a prescription. Looks like Oregon and California are allowing pharmacists to dispense these hormonal contraceptives without a valid prescription.</p>\r\n', '1637123507_one.jpg', '2021-11-17 10:01:47');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_brand`
--

CREATE TABLE `tbl_brand` (
  `brand_id` int(11) NOT NULL,
  `brand_name` varchar(255) NOT NULL,
  `brand_image` varchar(255) NOT NULL,
  `status` varchar(100) NOT NULL,
  `brand_date` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_brand`
--

INSERT INTO `tbl_brand` (`brand_id`, `brand_name`, `brand_image`, `status`, `brand_date`) VALUES
(4, 'Cadbury', '24842.jpg', 'Add', '2018-06-25 08:13:35'),
(5, 'Parle', '20388.png', 'Add', '2018-06-25 08:46:02'),
(6, 'Nestle', '2249.png', 'Add', '2018-06-25 12:08:24'),
(8, 'Britania', '6895.jpg', 'Add', '2018-06-26 06:08:32'),
(9, 'Sunfeast', '10748.jpg', 'Add', '2018-06-27 08:37:14'),
(10, 'Horlicks', '30921.jpg', 'Add', '2018-06-27 08:36:48'),
(11, 'Amul', '1067.jpg', 'Add', '2018-06-26 12:51:51');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_category`
--

CREATE TABLE `tbl_category` (
  `cat_id` int(11) NOT NULL,
  `cate_name` varchar(200) NOT NULL,
  `category_image` varchar(200) NOT NULL,
  `cate_desc` text NOT NULL,
  `stastus` varchar(50) NOT NULL,
  `home_status` varchar(11) NOT NULL,
  `dat` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_category`
--

INSERT INTO `tbl_category` (`cat_id`, `cate_name`, `category_image`, `cate_desc`, `stastus`, `home_status`, `dat`) VALUES
(1, 'ANTI-BIOTICS', '20064.', '', '', '', '2021-10-30 09:22:09'),
(2, 'GASTROINTESTINAL', '20249.', '', '', '', '2021-10-30 09:22:29'),
(5, 'GYNECOLOGICAL', '30446.', '', '', '', '2021-10-30 09:22:48'),
(6, 'RESPIRATORY & ANTI-COLD', '1019857447.', '', '', '', '2021-10-30 09:22:58'),
(7, 'ANTIHISTAMICS', '26132.', '', '', '', '2021-10-30 09:23:09'),
(8, 'ANTI-MALARIALS', '14872.', '', '', '', '2021-10-30 09:23:17'),
(9, 'NEUTRACEUTICALS & MULTIVITAMINS', '16061.', '', '', '', '2021-10-30 09:23:23'),
(10, 'PEDIATRICS', '31922.', '', '', '', '2021-10-30 09:23:27'),
(11, 'ENT & OPHTHALMIC DROPS', '15473.', '', '', '', '2021-10-30 09:23:38'),
(12, 'NEURO-PSYCHIATRIC', '23126.', '', '', '', '2021-10-30 09:23:43'),
(13, 'ANTI-FUNGAL', '1027.', '', '', '', '2021-10-30 09:23:50'),
(16, 'PAIN MANAGEMENT', '7562.', '', '', '', '2021-11-17 05:38:22'),
(17, '	OTHERS', '14360.', '', '', '', '2021-11-17 05:38:39');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_contact_desc`
--

CREATE TABLE `tbl_contact_desc` (
  `id` int(11) NOT NULL,
  `desc1` text NOT NULL,
  `desc2` text NOT NULL,
  `desc3` text NOT NULL,
  `image1` varchar(255) NOT NULL,
  `image2` varchar(255) NOT NULL,
  `image3` varchar(255) NOT NULL,
  `dat` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_contact_desc`
--

INSERT INTO `tbl_contact_desc` (`id`, `desc1`, `desc2`, `desc3`, `image1`, `image2`, `image3`, `dat`) VALUES
(1, '<p>We would like to introduce ourselves as a leading company of construction equipments. Shiv Enterprises was established in 2013 by Mr. Lokesh Who is the founder of the company. The company is devoted and engrossed in construction machinery from last 2 decades.&nbsp;</p>\r\n', 'Our support centers are staffed around the clock to provide you access to our industry-leading expertise in virtualization and years of experience supporting', 'We are the best traders in nut bolt industry. Our purpose provides the best quality, best service to customer and credit highest. Fastener nut bolt...', 'add-banner2.jpg', 'ab2.jpg', 'ab3.jpg', '2019-05-14 08:33:30');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_footer_logo`
--

CREATE TABLE `tbl_footer_logo` (
  `logo_id` int(11) NOT NULL,
  `logo_image_name` varchar(255) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_footer_logo`
--

INSERT INTO `tbl_footer_logo` (`logo_id`, `logo_image_name`) VALUES
(2, '1635586689_1.png');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_home_about`
--

CREATE TABLE `tbl_home_about` (
  `id` int(11) NOT NULL,
  `title_trust1` varchar(255) NOT NULL,
  `title_trust2` varchar(255) NOT NULL,
  `title_trust3` varchar(255) NOT NULL,
  `desc_trust1` text NOT NULL,
  `desc_trust2` text NOT NULL,
  `desc_trust3` text NOT NULL,
  `desc_exp` text NOT NULL,
  `title_exp1` varchar(255) NOT NULL,
  `title_exp2` varchar(255) NOT NULL,
  `desc_exp1` text NOT NULL,
  `desc_exp2` text NOT NULL,
  `image_sat` varchar(255) NOT NULL,
  `desc_sat` text NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_home_about`
--

INSERT INTO `tbl_home_about` (`id`, `title_trust1`, `title_trust2`, `title_trust3`, `desc_trust1`, `desc_trust2`, `desc_trust3`, `desc_exp`, `title_exp1`, `title_exp2`, `desc_exp1`, `desc_exp2`, `image_sat`, `desc_sat`) VALUES
(1, 'We\'ve Reputation for Excellence', 'We Build Partnerships', 'Guided by Commitment', 'We would like to introduce ourselves as a leading company of construction equipments.', 'We would like to introduce ourselves as a leading company of construction equipments.', 'We would like to introduce ourselves as a leading company of construction equipments.', '<p>We would like to introduce ourselves as a leading company of construction equipments. The company is devoted and engrossed in construction machinery from last 2 decades.</p>\r\n', 'A Team of Professionals', '5+ Years of Young', 'We would like to introduce ourselves as a leading company of construction equipments.', 'We would like to introduce ourselves as a leading company of construction equipments.', 'single-drum-roller-250x250.jpg', '<p>We would like to introduce ourselves as a leading company of construction equipments. Shiv Enterprises was established in 2013 by Mr. Lokesh Who is the founder of the company. The company is devoted and engrossed in construction machinery from last 2 decades.</p>\r\n');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_home_product`
--

CREATE TABLE `tbl_home_product` (
  `id` int(11) NOT NULL,
  `product_title` varchar(255) NOT NULL,
  `product_image` varchar(255) NOT NULL,
  `cat_id` int(11) NOT NULL,
  `product_desc` text NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_home_product`
--

INSERT INTO `tbl_home_product` (`id`, `product_title`, `product_image`, `cat_id`, `product_desc`) VALUES
(1, '', '1636619324_client-logo1.png', 0, ''),
(2, '', '1636619352_client-logo1.png', 0, '');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_legal_desc`
--

CREATE TABLE `tbl_legal_desc` (
  `legl_id` int(11) NOT NULL,
  `legl_desc` text NOT NULL,
  `page_name` varchar(100) NOT NULL,
  `intro_title` varchar(200) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_legal_desc`
--

INSERT INTO `tbl_legal_desc` (`legl_id`, `legl_desc`, `page_name`, `intro_title`) VALUES
(1, '<p>hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here&nbsp;hello i am testing here hello i am testing here</p>\r\n', 'shinegold', 'legal');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_news_letter`
--

CREATE TABLE `tbl_news_letter` (
  `news_letter_id` int(11) NOT NULL,
  `news_letter_email` varchar(100) NOT NULL,
  `news_letter_date` varchar(100) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_news_letter`
--

INSERT INTO `tbl_news_letter` (`news_letter_id`, `news_letter_email`, `news_letter_date`) VALUES
(2, 'shahilk289@gmail.com', ''),
(6, 'shahilk289@gmail.com', ''),
(12, '', '');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_product`
--

CREATE TABLE `tbl_product` (
  `pro_id` int(11) NOT NULL,
  `pid` varchar(255) NOT NULL,
  `pro_moq` varchar(255) NOT NULL,
  `pro_name` varchar(255) NOT NULL,
  `new` varchar(5) NOT NULL,
  `sale` varchar(5) NOT NULL,
  `pro_price` float NOT NULL,
  `pro_discount` text NOT NULL,
  `pro_code` varchar(200) NOT NULL,
  `discount` varchar(100) NOT NULL,
  `pro_quan` int(11) NOT NULL DEFAULT '0',
  `shopbyprice` int(11) NOT NULL,
  `shopbymoq` int(11) NOT NULL,
  `pro_scheme` varchar(255) NOT NULL,
  `pro_weight` varchar(255) NOT NULL,
  `pro_desc` text NOT NULL,
  `pro_specification` text NOT NULL,
  `pro_detail` text NOT NULL,
  `pro_image` varchar(255) NOT NULL,
  `pro_image1` varchar(255) NOT NULL,
  `ebra_name` varchar(255) NOT NULL,
  `status` varchar(100) NOT NULL,
  `unit` varchar(200) NOT NULL,
  `moq_status` varchar(100) NOT NULL,
  `pro_date` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP,
  `pro_title` text NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_product`
--

INSERT INTO `tbl_product` (`pro_id`, `pid`, `pro_moq`, `pro_name`, `new`, `sale`, `pro_price`, `pro_discount`, `pro_code`, `discount`, `pro_quan`, `shopbyprice`, `shopbymoq`, `pro_scheme`, `pro_weight`, `pro_desc`, `pro_specification`, `pro_detail`, `pro_image`, `pro_image1`, `ebra_name`, `status`, `unit`, `moq_status`, `pro_date`, `pro_title`) VALUES
(1, '1', '', 'Ageclav 625 Tablets', '', '', 0, '<p><strong>Indications</strong></p>\r\n\r\n<p>AGECLAV-625 (Amoxyciline 500 mg &amp; Clavulanic acid 125 mg) Tablet is indicated for the treatment of infections caused by amoxicillin-resistant organisms producing beta-lactamases sensitive to clavulanic acid: Upper Respiratory Tract Infections (UTI), such as sinusitis, recurrent otitis media, and tonsillitis; Lower Respiratory Tract Infections (RTI), such as bronchitis (caused by amoxicillin-resistant beta-lactamases producing Escherichia coli, Hemophilus influenzae and Hemophilus para-influenzae), and bronchopneumonia; Genitourinary Tract Infections (GTI), such as cystitis, urethritis, and pyelonephritis; Skin and soft tissue infections.</p>\r\n\r\n<p>AGECLAV-625 (Amoxyciline 500 mg &amp; Clavulanic acid 125 mg) Tablet is also effective in the treatment of infections caused by amoxicillin-sensitive organisms at the appropriate amoxycillin dosage since in this situation the clavulanic acid component does not contribute to the therapeutic effect. AGECLAV I.V is additionally useful for surgical prophylaxis.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>AGECLAV-625 (Amoxyciline 500 mg &amp; Clavulanic acid 125 mg) Tablet is not advocated for those with a history of hypersensitivity to beta-lactams, e.g. penicillins and cephalosporins. AGECLAV-625 is also contraindicated in those with previous history of amoxicillin-clavulanic acid-associated jaundice / hepatic dysfunction.</p>\r\n\r\n<p>AGECLAV-625 (Amoxyciline 500 mg &amp; Clavulanic acid 125 mg) Tablet should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform rash has been associated with this condition following the use of amoxicillin. AGECLAV-625 Tablet should not be used in renal failure when glomerular filtration rate is less than 30 ml/minute.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>AGECLAV-625 should be advocated with caution in presence of hepatic dysfunction or renal impairment. Since AGECLAV-625 contains amoxicillin, an aminopenicillin, it is not the treatment of choice in patients presenting with sore throat or pharyngitis because of the possibility that the underlying cause is infectious mononucleosis, in the presence of which there is a high incidence of rash if Amoxicillin is used.</p>\r\n\r\n<p>Periodic assessment of organ system functions, including renal, hepatic and hematopoietic function, is advisable during prolonged AGECLAV therapy. AGECLAV-625 (Amoxyciline 500 mg &amp; Clavulanic acid 125 mg) Tablet is not ideally meant for pregnant lady or lactating mother; however, it could be advocated only if strictly necessary. If superinfections occur (usually involving Aerobacter, Pseudomonas or Candida spp), AGECLAV-625 should be discontinued and/or appropriate therapy needs to be instituted. AGECLAV-625 must be co-administered with caution along with probenecid and allupurinol.</p>\r\n\r\n<p><strong>Adverse Reactions</strong></p>\r\n\r\n<p>The most frequently reported adverse effects with Amoxicillin Clavulanic Acid (AGECLAV) are indigestion, diarrhea, nausea, vomiting, abdominal pain, skin rashes, urticaria and erythema multiforme, vaginitis, oral thrush, abnormal taste, headache, dizziness, tiredness and hot flushes. Other side effects attributable to amoxicillin (AGECLAV) include hypersensitivity reactions, other gastrointestinal reactions including superficial tooth discoloration, hepatitis, cholestatic jaundice, hematologic changes and central nervous system effects including convulsions.</p>\r\n\r\n<p><strong>Drug Interaction</strong></p>\r\n\r\n<p>Probenecid decreases the renal tubular secretion of amoxicillin, but does not affect Clavulanic Acid excretion. The combined administration of allopurinol and ampicillin substantially increases the incidence of skin rashes and AGECLAV-625 must be cautiously co-administered with allupurinol.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>Adults:<br />\r\nMild-to-Moderate Infections: 1 AGECLAV 625 Tablet bid, or as prescribed.&nbsp; &nbsp; &nbsp; &nbsp;<br />\r\nSevere Infections: 1 AGECLAV 625 tid or as prescribed.</p>\r\n\r\n<p>Renal Impairment:<br />\r\nGlomerular filtration rate of 10-30 ml/min: 1 AGECLAV 375 / 625 BID depending upon the severity of infection.</p>\r\n\r\n<p>Hemodialysis: 1 AGECLAV 375 / 625 OD depending upon the severity of infection. Or as prescribed.</p>\r\n\r\n<p><strong>Presentations</strong><br />\r\nAGECLAV-625 Tablets: ALU ALU of 6s</p>\r\n', '113.21', '', 1, 0, 0, '', '', '', '', '', '17640.jpg', '', '', 'Add', '', '', '2021-11-17 05:17:55', '<p>Amoxicillin 500 mg &amp; Clavulanic Acid 125 mg Tablets</p>\r\n\r\n<p><strong>Composition</strong></p>\r\n\r\n<p>Each tablet of AGECLAV- 625 contains:<br />\r\nAmoxicillin Trihydrate Equivalent to Amoxicillin&hellip; 500 mg<br />\r\nClavulanate potassium Equivalent to Clavulanic acid&hellip; 125 mg</p>\r\n'),
(2, '1', '', 'Ageclav-228.5 Dry Syrup', '', '', 0, '<p><strong>Indications</strong></p>\r\n\r\n<p>AGECLAV Dry Syrup is indicated for the treatment of infections caused by amoxicillin-resistant organisms producing beta-lactamases sensitive to clavulanic acid: Upper Respiratory Tract Infections (UTI), such as sinusitis, recurrent otitis media, and tonsillitis; Lower Respiratory Tract Infections (RTI), such as bronchitis (caused by amoxicillin-resistant beta-lactamases producing Escherichia coli, Hemophilus influenzae and Hemophilus para-influenzae), and bronchopneumonia; Genitourinary Tract Infections (GTI), such as cystitis, urethritis, and pyelonephritis; Skin and soft tissue infections.</p>\r\n\r\n<p>AGECLAV is also effective in the treatment of infections caused by amoxicillin-sensitive organisms at the appropriate amoxycillin dosage since in this situation the clavulanic acid component does not contribute to the therapeutic effect. AGECLAV I.V is additionally useful for surgical prophylaxis.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>AGECLAV is not advocated for those with a history of hypersensitivity to beta-lactams, e.g. penicillins and cephalosporins. AGECLAV is also contraindicated in those with previous history of amoxicillin-clavulanic acid-associated jaundice / hepatic dysfunction.</p>\r\n\r\n<p>AGECLAV should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform rash has been associated with this condition following the use of amoxicillin. AGECLAV should not be used in renal failure when glomerular filtration rate is less than 30 ml/minute.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>AGECLAV should be advocated with caution in presence of hepatic dysfunction or renal impairment. Prolonged use of AGECLAV Dry Syrup could result in overgrowth of non-susceptible organisms. Since AGECLAV contains amoxicillin, an aminopenicillin, it is not the treatment of choice in patients presenting with sore throat or pharyngitis because of the possibility that the underlying cause is infectious mononucleosis, in the presence of which there is a high incidence of rash if Amoxicillin is used.</p>\r\n\r\n<p><strong>Adverse Reactions</strong></p>\r\n\r\n<p>The most frequently reported adverse effects with Amoxicillin Clavulanic Acid (AGECLAV) are indigestion, diarrhea, nausea, vomiting, abdominal pain, skin rashes, urticaria and erythema multiforme, vaginitis, oral thrush, abnormal taste, headache, dizziness, tiredness and hot flushes. Other side effects attributable to amoxicillin (AGECLAV) include hypersensitivity reactions, other gastrointestinal reactions including superficial tooth discoloration, hepatitis, cholestatic jaundice, hematologic changes and central nervous system effects including convulsions.</p>\r\n\r\n<p><strong>Drug Interaction</strong></p>\r\n\r\n<p>Probenecid decreases the renal tubular secretion of amoxicillin, but does not affect Clavulanic Acid excretion. The combined administration of allopurinol and ampicillin substantially increases the incidence of skin rashes and AGECLAV must be cautiously co-administered with allupurinol.</p>\r\n\r\n<p><strong>Dosage</strong></p>\r\n\r\n<p>AGECLAV DRY SYRUP<br />\r\nChildren: (Children below 15 kg</p>\r\n\r\n<p>To dose as per Amoxicillin and Clavulanic Acid recommendations of 25 mg/kg and 3.6/kg (respectively) per day in two divided doses, or as prescribed. Alternatively,</p>\r\n\r\n<p>3-9 months: 1.25 ml (&frac14; tsf) AGECLAV Suspension twice daily.<br />\r\n9 mths-2 yrs: 2.5 ml (&frac12; tsf) AGECLAV Suspension twice daily.<br />\r\n2-6 yrs: 5 ml (1 tsf) AGECLAV Suspension twice daily.<br />\r\n7-12 yrs: 10 ml (2 tsf) AGECLAV Suspension twice daily.</p>\r\n\r\n<p><strong>Presentations</strong><br />\r\nAGECLAV DRY SYRUP: 30 ml Bottle of Oral Suspension</p>\r\n', '52', '', 1, 0, 0, '', '', '', '', '', '781.jpg', '', '', 'Add', '', '', '2021-11-17 04:58:58', '<p>Amoxycillin 200 mg &amp; Clavulanic Acid 28.5 mg for Oral Suspension</p>\r\n\r\n<p><strong>Composition</strong><br />\r\nEach 5 ml of AGECLAV Dry Syrup contains:<br />\r\nAmoxicillin Trihydrate Equivalent to Amoxicillin&hellip; ...........200 mg<br />\r\nClavulanate Potassium Equivalent to Clavulanic Acid &hellip;28.5 mg</p>\r\n'),
(3, '1', '', 'Ageclav-1.2 Injection', '', '', 0, '0', '', '', 1, 0, 0, '', '', '', '', '', '12723.jpg', '', '', 'Add', '', '', '2021-10-30 09:35:26', ''),
(21, '3', '', 'Product Name', '', '', 0, '0', '', '', 1, 0, 0, '', '', '', '', '', '25798.jpg', '', '', '', '', '', '2021-11-17 04:18:38', 'fdff'),
(22, '1', '', 'Agex-sl 375 Tablets', '', '', 0, '<p><strong>Indications &amp; Usage</strong></p>\r\n\r\n<p>AGEX-SL 375 (Ceftriaxone 250 mg &amp; Sulbactam 125 mg) Injection is indicated for susceptible pathogens causing: Complicated intra-abdominal infections.</p>\r\n\r\n<ul>\r\n	<li>Recurrent Urinary Tract Infections (UTIs) since sensitivity of E coli to ceftriaxone alone maybe 74%.</li>\r\n	<li>Endocarditis due to ESBL elaborated by the pathogens.</li>\r\n	<li>Confirmed staphylococcal, K pneumoniae or P mirabilis infections.</li>\r\n	<li>Acinetobacter (banumannii) spp infections like nosocomial meningitis.</li>\r\n	<li>Gram negative infections in ICU patients: 97% maybe cross-resistant to ceftriaxone because of marked loss of ceftriaxone&#39;s activity on account of production of class A and C &szlig;-lactamases.</li>\r\n	<li>Pediatric respiratory infections because H influenzae is a common pathogen, and nearly 15% are &szlig;-lactamases producers.</li>\r\n	<li>Critically ill patients with any ceftriaxone-susceptible infecting pathogens.</li>\r\n	<li>Elderly patients with comorbid illness.</li>\r\n	<li>Neonatal septicemia.</li>\r\n	<li>Nosocomial infections since these bacteria are frequently &szlig;-lactamases producers (especially ESBL).</li>\r\n	<li>Necrotizing surgical site infection.</li>\r\n	<li>Resistant plague infection.</li>\r\n</ul>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>AGEX-SL is contraindicated in patients with known hypersensitivity to cephalosporin antibiotics. In patients hypersensitive to penicillin, consider the possibility of allergic cross-reactions. The use of sulbactam is contraindicated in individuals with a history of hypersensitivity reactions to any of the penicillins.</p>\r\n\r\n<p><strong>Special Precautions</strong></p>\r\n\r\n<p>Pregnancy and lactation</p>\r\n\r\n<p><strong>Other Drug Interactions</strong></p>\r\n\r\n<p>With aminoglycosides: Concomitant administration may increase risk of nephrotoxicity.<br />\r\nWith heparin/warfarin: Concurrent use may cause marked hypoprothrombinemia and/or prolonged bleeding time.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>Parenteral (IM/IV): Adults: 1-2 gm ceftriaxone per day as AGEX &ndash; SL IM / IV once daily (or in equally divided doses twice a day) depending up on the type and severity of the infection. The total daily dose of ceftriaxone should not exceed 4 gm.</p>\r\n\r\n<p>AGEX-SL therapy should generally be continued for at least 2 days after the signs and symptoms of infection have disappeared. The usual duration is 4 to 14 days; in complicated infections longer therapy may be required. While treating infections caused by Streptococcus pyogenes, the therapy should be continued for at least ten days.</p>\r\n\r\n<p>Surgical Prophylaxis: 1 gm ceftriaxone single dose as AGEX &ndash; SL IV &frac12; to 2 hours before surgery.<br />\r\nUncomplicated Gonococcal Infections: 250 mg ceftriaxone single dose as AGEX &ndash; SL IM.<br />\r\nChildren: 50 to 75 mg ceftriaxone/kg body-weight per day (not exceeding 2 gm) as AGEX &ndash; SL IM / IV in 2 divided doses every 12 hours.</p>\r\n\r\n<p>Meningitis: 100 mg ceftriaxone/kg body-weight per day (not exceeding 4 gm) as AGEX &ndash; SL IV initially; thereafter, 100 mg ceftriaxone/kg body-weight per day (maximum 4 gm/day) as AGEX- SL IV as single dose or in equally 2 divided doses every 12 hours for 7-14 days.</p>\r\n\r\n<p>Acute Bacterial Otitis Media: 50 mg ceftriaxone/kg body-weight per day (not exceeding 1 gm) as AGEX &ndash; SL IM single dose.</p>\r\n\r\n<p><strong>Presentations</strong></p>\r\n\r\n<p>AGEX-SL 350<br />\r\nTwin pack: Vial &amp; sterile water for injection as diluents.</p>\r\n', '43.40', '', 1, 0, 0, '', '', '', '', '', '31961.jpg', '', '', 'Add', '', '', '2021-11-17 05:12:48', '<p>Ceftriaxone 250 mg &amp; Sulbactam 125 mg Injection</p>\r\n\r\n<p><strong>Compositions</strong><br />\r\nEach vial of AGEX &ndash; SL 375 mg contains:<br />\r\nSterile Ceftriaxone Sodium IP Equivalent to Anhydrous Ceftriaxon&nbsp;250 mg<br />\r\nSterile Sulbactam Sodium USP Equivalent to Sulbactam&hellip;125 mg</p>\r\n'),
(23, '1', '', 'Ageclav-lb 625 Tablets', '', '', 0, '<p><strong>Composition</strong></p>\r\n\r\n<p>Each tablet of AGECLAV-LB 625 contains:<br />\r\nAmoxicillin Trihydrate Equivalent to Amoxicillin&hellip; .........500 mg<br />\r\nClavulanate potassium Equivalent to Clavulanic acid&hellip; 125 mg<br />\r\nLactic Acid Bacillus .............................................60 million spores</p>\r\n\r\n<p><strong>Indications</strong></p>\r\n\r\n<p>AGECLAV-LB 625 Tablet is indicated for the treatment of infections caused by amoxicillin-resistant organisms producing beta-lactamases sensitive to clavulanic acid: Upper Respiratory Tract Infections (UTI), such as sinusitis, recurrent otitis media, and tonsillitis; Lower Respiratory Tract Infections (RTI), such as bronchitis (caused by amoxicillin-resistant beta-lactamases producing Escherichia coli, Hemophilus influenzae and Hemophilus para-influenzae), and bronchopneumonia; Genitourinary Tract Infections (GTI), such as cystitis, urethritis, and pyelonephritis; Skin and soft tissue infections.</p>\r\n\r\n<p>AGECLAV-LB 625 Tablet is also effective in the treatment of infections caused by amoxicillin-sensitive organisms at the appropriate amoxycillin dosage since in this situation the clavulanic acid component does not contribute to the therapeutic effect. AGECLAV I.V is additionally useful for surgical prophylaxis.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>AGECLAV-LB 625 Tablet is not advocated for those with a history of hypersensitivity to beta-lactams, e.g. penicillins and cephalosporins. AGECLAV-LB 625 is also contraindicated in those with previous history of amoxicillin-clavulanic acid-associated jaundice / hepatic dysfunction.</p>\r\n\r\n<p>AGECLAV-LB 625 Tablet should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform rash has been associated with this condition following the use of amoxicillin. AGECLAV-LB 625 Tablet should not be used in renal failure when glomerular filtration rate is less than 30 ml/minute.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>AGECLAV-LB 625 should be advocated with caution in presence of hepatic dysfunction or renal impairment. Since AGECLAV-LB 625 contains amoxicillin, an aminopenicillin, it is not the treatment of choice in patients presenting with sore throat or pharyngitis because of the possibility that the underlying cause is infectious mononucleosis, in the presence of which there is a high incidence of rash if Amoxicillin is used.</p>\r\n\r\n<p>Periodic assessment of organ system functions, including renal, hepatic and hematopoietic function, is advisable during prolonged AGECLAV therapy. AGECLAV-LB 625 Tablet is not ideally meant for pregnant lady or lactating mother; however, it could be advocated only if strictly necessary. If superinfections occur (usually involving Aerobacter, Pseudomonas or Candida spp), AGECLAV-LB 625 should be discontinued and/or appropriate therapy needs to be instituted. AGECLAV-LB 625 must be co-administered with caution along with probenecid and allupurinol.</p>\r\n\r\n<p><strong>Adverse Reactions</strong></p>\r\n\r\n<p>The most frequently reported adverse effects with Amoxicillin and Clavulanic Acid (AGECLAV) are indigestion, diarrhea, nausea, vomiting, abdominal pain, skin rashes, urticaria and erythema multiforme, vaginitis, oral thrush, abnormal taste, headache, dizziness, tiredness and hot flushes. Other side effects attributable to amoxicillin (AGECLAV) include hypersensitivity reactions, other gastrointestinal reactions including superficial tooth discoloration, hepatitis, cholestatic jaundice, hematologic changes and central nervous system effects including convulsions. &nbsp; &nbsp; &nbsp;</p>\r\n\r\n<p><strong>Drug Interaction</strong></p>\r\n\r\n<p>Probenecid decreases the renal tubular secretion of amoxicillin, but does not affect Clavulanic Acid excretion. The combined administration of allopurinol and ampicillin substantially increases the incidence of skin rashes and AGECLAV-LB 625 must be cautiously co-administered with allupurinol.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>Adults:<br />\r\nMild-to-Moderate Infections: 1 AGECLAV-LB 625 Tablet bid, or as prescribed.&nbsp; &nbsp; &nbsp; &nbsp;<br />\r\nSevere Infections: 1 AGECLAV-LB 625 tid or as prescribed.</p>\r\n\r\n<p>Renal Impairment:<br />\r\nGlomerular filtration rate of 10-30 ml/min: 1 AGECLAV 375 / 625 BID depending upon the severity of infection.</p>\r\n\r\n<p>Hemodialysis: 1 AGECLAV 375 / 625 OD depending upon the severity of infection. Or as prescribed.</p>\r\n\r\n<p><strong>Presentations</strong><br />\r\nAGECLAV-625 Tablets: ALU ALU of 6s</p>\r\n', '135', '', 1, 0, 0, '', '', '', '', '', '20445.jpg', '', '', 'Add', '', '', '2021-11-17 12:18:06', '<p>Amoxycillin 500 mg + Clavulanic Acid 125 mg + Lactic Acid Bacillus 60 Million Spores&nbsp;</p>\r\n\r\n<p><strong>AGECLAV-LB 625 Tablets</strong><br />\r\nAmoxicillin 500 mg, Clavulanic Acid 125 mg &amp; Lactic Acid Bacillus 60 Million Spores Tablets</p>\r\n'),
(24, '22', '', 'Ageclin-c', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '31282.jpg', '', '', '', '', '', '2021-11-17 05:30:50', ''),
(27, '24', '', 'Agecort-6 Tablets', '', '', 0, '<p><strong>Indications</strong></p>\r\n\r\n<ul>\r\n	<li>Anaphylaxis, asthma, severe hypersensitivity reactions</li>\r\n	<li>Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica</li>\r\n	<li>Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyarteritis nodosa, sarcoidosis</li>\r\n	<li>Pemphigus, bullous pemphigoid, pyoderma gangrenosum</li>\r\n	<li>Minimal change nephrotic syndrome, acute interstitial nephritis</li>\r\n	<li>Rheumatic carditis</li>\r\n	<li>Ulcerative colitis, Crohn&#39;s disease</li>\r\n	<li>Uveitis, optic neuritis</li>\r\n	<li>Autoimmune haemolytic anaemia, idiopathic thrombocytopenic purpura</li>\r\n	<li>Acute and lymphatic leukaemia, malignant lymphoma, multiple myeloma</li>\r\n	<li>Immune suppression in transplantation</li>\r\n</ul>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Systemic infection unless specific anti-infective therapy is employed. Hypersensitivity to deflazacort or any of the ingredients. Patients receiving live virus immunisation.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Patients with rare hereditary problems of galactose intolerance, the Lapp lactose deficiency or glucose-galactose malabsorption should not take this medicine.</p>\r\n\r\n<p>Undesirable effects may be minimised by using the lowest effective dose for the minimum period, and by administering the daily requirement as a single morning dose or whenever possible as a single morning dose on alternate days. Frequent patient review is required to appropriately titrate the dose against disease activity.</p>\r\n\r\n<p><strong>Drug Interactions</strong></p>\r\n\r\n<p>Deflazacort is metabolised in the liver. It is recommended to increase the maintenance dose of deflazacort if drugs which are liver enzyme inducers are co-administered, e.g. rifampicin, rifabutin, carbamazepine, phenobarbitone, phenytoin, primidone and aminoglutethimide. For drugs which inhibit liver enzymes, e.g. ketoconazole it may be possible to reduce the maintenance dose of deflazacort.</p>\r\n\r\n<p>In patients taking estrogens, corticosteroid requirements may be reduced.</p>\r\n\r\n<p>The desired effects of hypoglycaemic agents (including insulin), anti-hypertensives and diuretics are antagonised by corticosteroids and the hypokalaemic effects of acetazolamide, loop diuretics, thiazide diuretics, beta 2-agonists, xanthines and carbenoxolone are enhanced.</p>\r\n\r\n<p>The efficacy of coumarin anticoagulants may be enhanced by concurrent corticosteroid therapy and close monitoring of the INR or prothrombin time is required to avoid spontaneous bleeding.</p>\r\n\r\n<p>In patients treated with systemic corticosteroids, use of non-depolarising muscle relaxants can result in prolonged relaxation and acute myopathy. Risk factors for this include prolonged and high dose corticosteroid treatment, and prolonged duration of muscle paralysis. This interaction is more likely following prolonged ventilation (such as in the ITU setting). The renal clearance of salicylates is increased by corticosteroids and steroid withdrawal may result in salicylate intoxication.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>As prescribed by the physician.</p>\r\n\r\n<p><strong>Presentation</strong></p>\r\n\r\n<p>AGECORT-6 Tablets: Alu Alu of 10s</p>\r\n\r\n<ul>\r\n</ul>\r\n', '89.00', '', 1, 0, 0, '', '', '', '', '', '13485.jpg', '', '', 'Add', '', '', '2021-11-17 12:17:22', '<p>Deflazacort 6 mg</p>\r\n\r\n<p><strong>Composition</strong><br />\r\nEach tablet of AGECORT-6 contains:<br />\r\nDeflazacort..........6 mg</p>\r\n'),
(28, '24', '', 'Agecort-6 Suspension', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '30207.jpg', '', '', 'Add', '', '', '2021-11-17 12:17:23', ''),
(29, '24', '', 'Ageflox-OZ Suspention', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '28329.jpg', '', '', '', '', '', '2021-11-17 05:48:04', ''),
(30, '25', '', 'Agelax', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '19557.jpg', '', '', '', '', '', '2021-11-17 05:52:22', ''),
(31, '26', '', 'Ageliv-150 Tablets', '', '', 0, '<p><strong>Indications &amp; Usage</strong></p>\r\n\r\n<ul>\r\n	<li>Cholesterol Gallstone: AGELIV (Ursodeoxycholic Acid) Tablets from Agex Laboratories may be indicated for dissolution of cholesterol gallstones in selected patients with uncomplicated radiolucent gallstone disease. Ageliv therapy is more likely to be effective if the stones are small (&lt; 20 mm) and of the floatable type.</li>\r\n	<li>Biliary Atresia</li>\r\n	<li>Sclerosing cholangitis</li>\r\n	<li>Alcoholic Cirrhosis</li>\r\n	<li>Biliary Cirrhosis</li>\r\n	<li>Cholestatic Hepatic disease</li>\r\n	<li>Cystic fibrosis&ndash;associated hepatic disease</li>\r\n	<li>Chronic Hepatitis</li>\r\n	<li>Liver transplant rejection: Ageliv (Ursodeoxycholic Acid) is used as adjuvant therapy following orthotopic liver transplantation to prevent early graft rejection.</li>\r\n</ul>\r\n\r\n<p>Ageliv is not indicated when there are calcified cholesterol stones, radiopaque stones (calcium-containing), or radiolucent bile pigment stones; when the gallbladder is not functioning; or when surgery for gallstones is clearly indicated.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Sensitivity to Ageliv (Ursodeoxycholic acid) or other bile acids.</p>\r\n\r\n<p><strong>Precautions &amp; Warning</strong></p>\r\n\r\n<p>Patients sensitive to other bile acid products may be sensitive to Ursodeoxycholic acid also.<br />\r\nAs far as pregnancy is concerned, well-controlled studies have not been done in humans. Studies in rats at doses 20 to 100 times the human dose, and in rabbits at doses 5 times the human dose, have not shown that Ursodeoxycholic acid causes adverse effects in the fetus.</p>\r\n\r\n<p>It is not known whether Ursodeoxycholic is distributed into breast milk.</p>\r\n\r\n<p><strong>Pediatrics</strong>: Appropriate studies on the relationship of age to the effects of Ursodeoxycholic acid when used as an anticholelithic have not been performed in the pediatric population. However, studies performed to date in children and infants with cholestatic liver disease and biliary atresia have not demonstrated pediatrics-specific problems that would limit the usefulness of Urdodeoxycholic acid in children.</p>\r\n\r\n<p><strong>Drug Interactions</strong><br />\r\nConcurrent use of Antacids or Cholestyramine or Colestipol may result in binding of Ageliv, thus decreasing its absorption.</p>\r\n\r\n<p>Concurrent use of antihyperlipidemics, especially clofibrate or estrogens or neomycin or progestins with Ageliv may decrease its ability to dissolve cholesterol gallstones, since these medications tend to increase cholesterol saturation of bile.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong><br />\r\nUsual adult and adolescent dose<br />\r\n<strong>Gallstone disease</strong>: Oral, 8 to 10 mg per kg of body weight a day, divided into two or three doses, usually taken with meals.<br />\r\n<strong>Gallstone formation</strong>: Oral, 300 mg two times a day.<br />\r\n<strong>Cholestatic Hepatic disease</strong>: Oral, 13 to 15 mg per kg of body weight a day, given in two divided doses (morning and bedtime) with food.</p>\r\n\r\n<p><strong>Usual pediatric dose</strong><br />\r\n<strong>Anticholelithic</strong>: Dosage has not been established.<br />\r\n<strong>Cholestatic liver disease and extrahepatic biliary atresia</strong>: 10 to 18 mg per kg of body weight.</p>\r\n\r\n<p><strong>Presentation</strong><br />\r\nAgeliv-150 Tablets: Alu Alu of 10s</p>\r\n', '225.00', '', 1, 0, 0, '', '', '', '', '', '22344.jpg', '', '', '', '', '', '2021-11-17 05:57:02', '<p>AGELIV-150 Tablets Ursodesoxycholic Acid 150 mg&nbsp;</p>\r\n\r\n<p><strong>Compostion</strong></p>\r\n\r\n<p>Each film coated tablet contains:<br />\r\nUrsodeoxycholic Acid BP....150 mg<br />\r\nExcipients &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; q.s.<br />\r\nColours: Red Oxide of Iron &amp; Titanium Dioxide IP</p>\r\n'),
(32, '26', '', 'Ageliv-300 Tablets', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '18913.jpg', '', '', '', '', '', '2021-11-17 05:58:25', ''),
(33, '27', '', 'Agemith Tablets', '', '', 0, '<p><strong>Composition</strong></p>\r\n\r\n<p>Each tablet of METHICAL-M contains:</p>\r\n\r\n<p>Methylcobalamin............1500 mcg<br />\r\nCalcium Citrate...............210 mg&nbsp;</p>\r\n\r\n<p>Calcitriol..........................0.25 mg<br />\r\nVitamin B6.......................3 mg<br />\r\nFolic Acid........................1.5 mg</p>\r\n\r\n<p><strong>Indications</strong></p>\r\n\r\n<ul>\r\n	<li>Osteoporosis</li>\r\n	<li>Softening of Bones</li>\r\n	<li>Hypocalcaemia</li>\r\n	<li>Rickets with Osteomalacia</li>\r\n	<li>Osteodystrophy</li>\r\n	<li>Pregnancy &amp; Lactation</li>\r\n</ul>\r\n\r\n<p><strong>Dosage</strong><br />\r\nAs prescribed by the dietician</p>\r\n\r\n<p><strong>Presentation</strong><br />\r\nAGEMITH Tablets: Alu Alu of 10s</p>\r\n', '150', '', 1, 0, 0, '', '', '', '', '', '29467.jpg', '', '', '', '', '', '2021-11-17 06:02:01', '<p>AGEMITH Tablet<br />\r\nMethylcobalamin 1500 mcg, Calcium Citrate 210 mg, Calcitriol 0.25 mg, Vitamin B6 3 mg &amp; Folic Acid 1.5 mg Tablet</p>\r\n'),
(34, '28', '', 'Ageplex-L 100 ML', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '24054.jpg', '', '', '', '', '', '2021-11-17 06:05:12', ''),
(35, '28', '', 'Ageplex-L 200 ML', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '28515.jpg', '', '', '', '', '', '2021-11-17 06:06:16', ''),
(36, '29', '', 'Agerim-200', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '7871.jpg', '', '', '', '', '', '2021-11-17 06:08:40', ''),
(37, '29', '', 'Agerim-400', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '7268.jpg', '', '', '', '', '', '2021-11-17 06:09:38', ''),
(38, '30', '', 'Agex-4G', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '6864.jpg', '', '', '', '', '', '2021-11-17 06:11:47', ''),
(39, '30', '', 'Agex-500 INJ', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '19009.jpg', '', '', '', '', '', '2021-11-17 06:13:02', ''),
(40, '31', '', 'Agexa-200 Tablets', '', '', 0, '<p><strong>Indications &amp; Usage</strong></p>\r\n\r\n<ul>\r\n	<li>Acute bacterial exacerbation of chronic bronchitis</li>\r\n	<li>Community-acquired pneumonia</li>\r\n	<li>Acute pelvic inflammatory disease (PID)</li>\r\n	<li>Acute, uncomplicated cervical and urethral gonorrhea</li>\r\n	<li>Urethritis</li>\r\n	<li>Cervicitis</li>\r\n	<li>Uncomplicated cystitis</li>\r\n	<li>Uncomplicated skin and skin structure</li>\r\n	<li>Complicated UTIs</li>\r\n	<li>Prostatitis</li>\r\n	<li>MDR TB &nbsp; &nbsp; &nbsp;</li>\r\n</ul>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>AGEXA-200 (ofloxacin 200mg) is contraindicated in those with known hypersensitivity to its ingredients, pregnant women, or those having possibilities of being pregnant, and in children. Breast feeding is to be avoided whilst on AGEXA treatment.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>AGEXA - 200 is to be advocated with caution in severe nephropathy, convulsive disorders, known hyper sensitivity to quinolones and in elderly patients. It should be co-administered with caution along with nonsteroidal anti-inflammatory drugs, antacids, hematinics and anticoagulants.</p>\r\n\r\n<p><strong>Adverse Reactions</strong></p>\r\n\r\n<p>AGEXA-200 can cause gastrointestinal intolerance, psychoneurologic symptoms and allergic reactions. It can rarely cause malaise, fever, palpitations, taste abnormality, convulsions, acute renal failure, jaundice, hematologic abnormalities, rhabdomyolysis, hypoglycemia in susceptible diabetics, tendon disorders and psychiatric symptoms such as confusion.</p>\r\n\r\n<p><strong>Drug Interaction</strong></p>\r\n\r\n<p>Ofloxacin (AGEXA - 200) can interact with nonsteroidal anti-inflammatory drugs, antacids, hematinics and anticoagulants.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>Adults: AGEXA-200 Tablet twice daily depending on the severity of infection, or as prescribed.</p>\r\n\r\n<p><strong>Presentations</strong><br />\r\nAGEXA-200 Tablet: Blister of 10s.</p>\r\n', '58.90', '', 1, 0, 0, '', '', '', '', '', '31433.jpg', '', '', '', '', '', '2021-11-17 06:17:24', '<p>Ofloxacin 200 mg Tablets</p>\r\n\r\n<p><strong>Composition</strong><br />\r\nEach tablet of AGEXA-200 contains<br />\r\nOfloxacin &hellip; 200mg</p>\r\n'),
(41, '31', '', 'Agexa-Ms Syrup', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '18813.jpg', '', '', '', '', '', '2021-11-17 06:20:46', ''),
(42, '31', '', 'Agexa-OZ Tablets', '', '', 0, '<p><strong>Contraindications</strong><br />\r\nAGEXA-OZ (Ofloxacin 200 mg &amp; Ornidazole 500 mg) Tablet from AGEX LABORATORIES PVT LTD is contraindicated in those with known hypersensitivity to its ingredients, pregnant women, or those having possibilities of being pregnant, and in children. Breast feeding is to be avoided whilst on AGEXA-OZ treatment.</p>\r\n\r\n<p>Hypersensitivity to ornidazole ( in AGEXA-OZ) or to other nitroimidazole derivatives.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>AGEXA-OZ from Agex Laboratories is to be advocated with caution in severe nephropathy, convulsive disorders, known hyper sensitivity to quinolones and in elderly patients. It should be co-administered with caution along with nonsteroidal anti-inflammatory drugs, antacids, hematinics and anticoagulants.</p>\r\n\r\n<p>Special Precautions and hepatic impairment. CNS diseases e.g. epilepsy or multiple sclerosis. May impair ability to drive or operate machinery, pregnancy and lactation.</p>\r\n\r\n<p><strong>Adverse Reactions</strong></p>\r\n\r\n<p>AGEXA-OZ may cause gastrointestinal intolerance, psychoneurologic symptoms and allergic reactions. It can rarely cause malaise, fever, palpitations, taste abnormality, convulsions, acute renal failure, jaundice, hematologic abnormalities, rhabdomyolysis, hypoglycemia in susceptible diabetics, tendon disorders and psychiatric symptoms such as confusion.</p>\r\n\r\n<p>Ornidazole (in AGEXA-OZ ) can cause Somnolence, headache, nausea, vomiting, dizziness, tremor, rigidity, poor coordination, seizures, tiredness, vertigo, temporary loss of consciousness and signs of sensory or mixed peripheral neuropathy, taste disturbances, abnormal LFTs, skin reactions</p>\r\n\r\n<p>&nbsp;<strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>Oral Administration<br />\r\nAdults:<br />\r\nAGEXA-OZ Tablet twice daily or as prescribed</p>\r\n\r\n<p><strong>Presentations</strong><br />\r\nAGEXA-OZ Tablet: Alu Alu of 10s.</p>\r\n', '82', '', 1, 0, 0, '', '', '', '', '', '13774.jpg', '', '', '', '', '', '2021-11-17 06:23:34', '<p>Ofloxacin 200 mg &amp; Ornidazole 500 mg Tablets</p>\r\n\r\n<p><strong>Composition</strong><br />\r\nEach tablet of AGEXA-OZ Tab contains:<br />\r\nOfloxacin &hellip; 200 mg/ 50 mg<br />\r\nOrnidazole&hellip;500 mg/ 125 mg</p>\r\n'),
(43, '30', '', 'Agex-Cold Syrup', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '6357.jpg', '', '', '', '', '', '2021-11-17 06:26:58', ''),
(44, '30', '', 'Agex-Cold Tablets', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '23791.jpg', '', '', '', '', '', '2021-11-17 06:28:12', ''),
(45, '32', '', 'Agexee Tablets', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '3289.jpg', '', '', '', '', '', '2021-11-17 06:32:21', ''),
(46, '30', '', 'Agex-Sl 375', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '25983.jpg', '', '', '', '', '', '2021-11-17 06:34:12', ''),
(47, '30', '', 'Agex SL 375', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '24794.jpg', '', '', '', '', '', '2021-11-17 06:37:55', ''),
(48, '30', '', 'Agex-SL 750', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '6476.jpg', '', '', '', '', '', '2021-11-17 06:38:45', ''),
(49, '7', '', 'Agextil-50 Dry Syrup', '', '', 0, '<p><strong>Indications</strong></p>\r\n\r\n<ul>\r\n	<li>URTIs &amp; LRTIs</li>\r\n	<li>UTIs</li>\r\n	<li>SSTIs</li>\r\n	<li>Typhoid Fever</li>\r\n</ul>\r\n\r\n<p><strong>Contraindications</strong><br />\r\nCefpodoxime is contraindicated to the patient with hypersensitivity with cephalosporin.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong><br />\r\nBefore therapy AGEXTIL-50 (Cefpodoxime 50 mg) Dry Syrup is instituted, careful inquiry should be made to determine whether the patient has had previous hypersensitivity reactions to cephalosporin, penicillins.<br />\r\nAGEXTIL (Cefpodoxime) is broad-spectrum antibiotics and should be prescribed with caution in individuals with a history of colitis.</p>\r\n\r\n<p><strong>Adverse Reaction</strong><br />\r\nAGEXTIL-50 (Cefpodoxime 50 mg) Dry Syrup may cause side effects like diarrhea, nausea, vaginal infections, headache, abdominal pain, mild skin rashes, hives, chest pain, and irregular heart beat.</p>\r\n\r\n<p><strong>Drug Interactions</strong></p>\r\n\r\n<ul>\r\n	<li>Carbamazepine: Elevated carbamazepine levels have been reported when cefpodoxime is administered concomitantly.</li>\r\n	<li>Warfarin and Anticoagulants: Increased prothrombin time, with or without clinical bleeding, has been reported when cefpodoxime is administered concomitantly.</li>\r\n</ul>\r\n\r\n<p><strong>Dosage</strong></p>\r\n\r\n<p>Children Bronchitis: Acute bacterial exacerbation of chronic bronchitis: 12 years or older: 200 mg orally every 12 hours for 10 days.</p>\r\n\r\n<p>Cystitis: 12 years or older: 100 mg orally every 12 hours for 7 days</p>\r\n\r\n<p>Gonococcal Infection &ndash; Uncomplicated: Uncomplicated urethral, cervical, or female anorectal infections: 12 years or older: 200 mg orally one time</p>\r\n\r\n<p>Gonococcal Infection &ndash; Disseminated: 12 years or older: 400 mg orally twice a day</p>\r\n\r\n<p>Otitis Media: 2 months through 12 years: 5 mg/kg/dose (maximum 200 mg) orally every 12 hours for 5 days; Maximum dose: 400 mg/day</p>\r\n\r\n<p>Community-acquired pneumonia: 12 years or older: 200 mg orally every 12 hours for 14 days</p>\r\n\r\n<p>Sinusitis: 2 months through 12 years: 5 mg/kg/dose (maximum 200 mg) orally every 12 hours for 10 days. Maximum dose: 400 mg/day. 12 years or older: 200 mg orally every 12 hours for 10 days</p>\r\n\r\n<p>Uncomplicated Skin or Soft Tissue Infection: 12 years or older: 400 mg orally every 12 hours for 7 to 14 days</p>\r\n\r\n<p>Tonsillitis/Pharyngitis: 2 months through 12 years: 5 mg/kg/dose (maximum 100 mg) orally every 12 hours for 5 to 10 days. Maximum dose: 200 mg/day. 12 years or older: 100 mg orally every 12 hours for 5 to 10 days.</p>\r\n\r\n<p><strong>Presentations</strong><br />\r\nAGEXTIL-50: Bottle of 30 ml with measuring cap</p>\r\n', '82', '', 1, 0, 0, '', '', '', '', '', '4210.jpg', '', '', '', '', '', '2021-11-17 06:42:53', '<p>Cefpodoxime 50 mg for Oral Suspension</p>\r\n\r\n<p><strong>Compositions</strong><br />\r\nEach 5 ml of suspension of AGEXTIL 50 contains<br />\r\nCefpodoxime proxetil USP equivalent to Cefpodoxime&hellip;50 mg</p>\r\n'),
(50, '7', '', 'Agextil-200 Tablets', '', '', 0, '<p><strong>Indications</strong></p>\r\n\r\n<ul>\r\n	<li>URTIs &amp; LRTIs</li>\r\n	<li>UTIs</li>\r\n	<li>SSTIs</li>\r\n	<li>Typhoid Fever</li>\r\n</ul>\r\n\r\n<p><strong>Contraindications</strong><br />\r\nCefpodoxime is contraindicated to the patient with hypersensitivity with cephalosporin.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong><br />\r\nBefore therapy AGEXTIL (Cefpodoxime) from Agex Laboratories is instituted, careful inquiry should be made to determine whether the patient has had previous hypersensitivity reactions to cephalosporin, penicillins.<br />\r\nAGEXTIL (Cefpodoxime) is broad-spectrum antibiotics and should be prescribed with caution in individuals with a history of colitis. AGEXTIL should be used in pregnant women and nursing mother only if needed, because safety has not been clearly established.</p>\r\n\r\n<p><strong>Adverse Reaction</strong><br />\r\nAGEXTIL-200 Tablets may cause side effects like diarrhea, nausea, vaginal infections, headache, abdominal pain, mild skin rashes, hives, chest pain, and irregular heart beat.</p>\r\n\r\n<p><strong>Drug Interactions</strong><br />\r\nCarbamazepine: Elevated carbamazepine levels have been reported when cefpodoxime is administered concomitantly.</p>\r\n\r\n<p>Warfarin and Anticoagulants: Increased prothrombin time, with or without clinical bleeding, has been reported when cefpodoxime is administered concomitantly.</p>\r\n\r\n<p>Oral Contraceptives: cefpodoxime may interfere with the effectiveness of birth control pills</p>\r\n\r\n<p><strong>Dosage</strong></p>\r\n\r\n<p>Adults</p>\r\n\r\n<p>Bronchitis: Acute bacterial exacerbation of chronic bronchitis: 200 mg orally every 12 hours for 10 days Cystitis: 100 mg orally every 12 hours for 7 days Gonococcal Infection &ndash; Uncomplicated: Uncomplicated urethral, cervical, or female anorectal infections: 200 mg orally one time Gonococcal Infection &ndash; Disseminated: 400 mg orally twice a day Community-acquired pneumonia: 200 mg orally every 12 hours for 14 days Pyelonephritis: 100 mg orally every 12 hours. Therapy should be continued for about 14 days, depending on the nature and severity of the infection. Sinusitis: 200 mg orally every 12 hours for 10 days Skin or Soft Tissue Infection: Uncomplicated infection: 400 mg orally every 12 hours for 7 to 14 days Tonsillitis/Pharyngitis: 100 mg orally every 12 hours for 5 to 10 days There are insufficient data to establish efficacy in the subsequent prophylaxis of rheumatic fever. Upper Respiratory Tract Infection: 100 mg orally every 12 hours. Therapy should be continued for approximately 10 to 14 days, depending on the nature and severity of the infection.</p>\r\n\r\n<p><strong>Presentations</strong><br />\r\nAGEXTIL-200: Alu Alu of 10s</p>\r\n\r\n<p>&nbsp;</p>\r\n', '199.00', '', 1, 0, 0, '', '', '', '', '', '27843.jpg', '', '', '', '', '', '2021-11-17 06:48:06', '<p>Cefpodoxime 200 mg Tablets</p>\r\n\r\n<p><strong>Compositions</strong></p>\r\n\r\n<p>Each AGEXTIL 200 dispersible tablet contains<br />\r\nCefpodoxime Proxetil equivalent to Cefpodoxime&hellip;200 mg</p>\r\n'),
(51, '7', '', 'Agextil-CV Dry Syrup', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '26944.jpg', '', '', '', '', '', '2021-11-17 06:49:49', ''),
(52, '7', '', 'Agextil-CV Tab', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '121.jpg', '', '', '', '', '', '2021-11-17 06:51:41', ''),
(53, '7', '', 'Agextil-CV TAB', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '16830.jpg', '', '', '', '', '', '2021-11-17 06:53:04', ''),
(54, '33', '', 'Agextim-500 Tablets', '', '', 0, '<p><strong>Indications &amp; Usage</strong></p>\r\n\r\n<p>AGEXTIM-500 (Cefuroxime Axetil 500 mg) Tablet from Agex Laboratories is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions given below:</p>\r\n\r\n<ul>\r\n	<li>Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.</li>\r\n	<li>Acute Bacterial Otitis Media caused by Streptococcus pneumonia.</li>\r\n	<li>Haemophilus influenzae (including beta-lactamase&ndash;producing strains).</li>\r\n	<li>Acute Bacterial Maxillary Sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non-beta-lactamase&ndash;producing strains only).</li>\r\n	<li>Acute Bacterial Exacerbations of Chronic Bronchitis and Secondary Bacterial Infections of Acute Bronchitis caused by Streptococcus pneumoniae, Haemophilus influenza (beta-lactamase negative strains), or Haemophilus parainfluenzae</li>\r\n	<li>Uncomplicated Skin and Skin-Structure Infections caused by Staphylococcus aureus</li>\r\n	<li>Uncomplicated Urinary Tract Infections caused by Escherichia coli or Klebsiella pneumoniae.</li>\r\n	<li>Uncomplicated Gonorrhea, urethral and endocervical, caused by penicillinase-producing and non-penicillinase&ndash;producing strains of Neisseria gonorrhoeae and uncomplicated gonorrhea, rectal, in females, caused by nonpenicillinase&ndash;producing strains of Neisseria gonorrhoeae.</li>\r\n	<li>Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi.</li>\r\n</ul>\r\n\r\n<p><strong>Contraindications</strong><br />\r\nCefuroxime Axetil tablets are contraindicated in patients with known allergy to the cephalosporin group of antibiotics.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong><br />\r\nCefuroxime Axetil tablets and Cefuroxime Axetil for Oral Suspension are not Bioequivalent and are therefore not substituted on a miligram per miligram basis.A careful inquire is recommended before Cefuroxime Axetil therapy is instituted. It is needed to determine if the patient has had previous hyper-sensivity reactions to Cefuroxime Axetil products, other Cephalosporins, Penicilllins, or other drugs.Nursing Mothers: Because cefuroxime is excreted in human milk, consideration should be given to discontinuing nursing temporarily during treatment with Cefuroxime Axetil.</p>\r\n\r\n<p><strong>Drug Interactions</strong></p>\r\n\r\n<p>Concomitant administration of probenecid with Cefuroxime Axetil tablets increases the area under the serum concentration versus time curve by 50%. The peak serum cefuroxime concentration after a 1.5 g single dose is greater when taken with 1 g of probenecid (mean = 14.8 mcg/mL) than without probenecid (mean = 12.2 mcg/mL).</p>\r\n\r\n<p>Drugs that reduce gastric acidity may result in a lower bioavailability of Cefuroxime Axetil tablets compared with that of fasting state and tend to cancel the effect of postprandial absorption.</p>\r\n\r\n<p>In common with other antibiotics, Cefuroxime Axetil may affect the gut flora, leading to lower estrogen reabsorption and reduced efficacy of combined oral estrogen/ progesterone contraceptives.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>Adult Dose</p>\r\n\r\n<p>Bronchitis: 250 to 500 mg orally twice a day for 5 to 10 days. Cystitis: 250 mg orally twice a day for 7 to 10 days Uncomplicated infections of the cervix, urethra, or rectum: 1 g orally one time Lyme Disease: 500 mg orally twice a day for 20 days Otitis Media: 250 mg orally twice a day for 10 days Peritonitis: 750 mg to 1.5 g every 8 hours for 10 to 14 days Pyelonephritis: 750 mg to 1.5 g every 8 hours or 250 to 500 mg orally twice a day for 14 days, depending on the nature and severity of the infection Sinusitis: 250 mg orally twice a day for 10 to 14 days Skin or Soft Tissue Infection: 250 mg to 500 mg orally twice a day Tonsillitis/Pharyngitis: 250 mg orally twice a day for 10 days Upper Respiratory Tract Infection: 250 to 500 mg orally twice a day Urinary Tract Infection: 250 mg orally twice a day for 7 to 10 days</p>\r\n\r\n<p>&nbsp;</p>\r\n', '496', '', 1, 0, 0, '', '', '', '', '', '27985.jpg', '', '', '', '', '', '2021-11-17 06:58:20', '<p>Cefuroxime Axetil IP 500 mg Tablets</p>\r\n\r\n<p><strong>Compositions</strong><br />\r\nEach AGEXTIM-500 film coated tablets contains<br />\r\nCefuroxime Axetil IP equivalent to Cefuroxime&hellip; 500 mg</p>\r\n'),
(55, '33', '', 'Agextim-1.5', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '27062.jpg', '', '', '', '', '', '2021-11-17 07:00:03', '');
INSERT INTO `tbl_product` (`pro_id`, `pid`, `pro_moq`, `pro_name`, `new`, `sale`, `pro_price`, `pro_discount`, `pro_code`, `discount`, `pro_quan`, `shopbyprice`, `shopbymoq`, `pro_scheme`, `pro_weight`, `pro_desc`, `pro_specification`, `pro_detail`, `pro_image`, `pro_image1`, `ebra_name`, `status`, `unit`, `moq_status`, `pro_date`, `pro_title`) VALUES
(56, '33', '', 'Agextim-125 Dry Syrup', '', '', 0, '<p><strong>Indications</strong></p>\r\n\r\n<p>AGEXTIM-125 (Cefuroxime Axetil 125 mg for oral suspension) Dry Syrup from Agex Laboratories is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions given below:</p>\r\n\r\n<ul>\r\n	<li>Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.</li>\r\n	<li>Acute Bacterial Otitis Media caused by Streptococcus pneumonia.</li>\r\n	<li>Haemophilus influenzae (including beta-lactamase&ndash;producing strains).</li>\r\n	<li>Acute Bacterial Maxillary Sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non-beta-lactamase&ndash;producing strains only).</li>\r\n	<li>Acute Bacterial Exacerbations of Chronic Bronchitis and Secondary Bacterial Infections of Acute Bronchitis caused by Streptococcus pneumoniae, Haemophilus influenza (beta-lactamase negative strains), or Haemophilus parainfluenzae</li>\r\n	<li>&nbsp;Uncomplicated Skin and Skin-Structure Infections caused by Staphylococcus aureus</li>\r\n	<li>Uncomplicated Urinary Tract Infections caused by Escherichia coli or Klebsiella pneumoniae.</li>\r\n	<li>Uncomplicated Gonorrhea, urethral and endocervical, caused by penicillinase-producing and non-penicillinase&ndash;producing strains of Neisseria gonorrhoeae and uncomplicated gonorrhea, rectal, in females, caused by nonpenicillinase&ndash;producing strains of Neisseria gonorrhoeae.</li>\r\n	<li>Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi.</li>\r\n</ul>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>AGEXTIM-125 (Cefuroxime Axetil 125 mg for Oral Suspension) Dry Syrup is contraindicated in patients with known allergy to the cephalosporin group of antibiotics.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>AGEXTIM-125 (Cefuroxime Axetil 125 mg for Oral Suspension) Dry Syrup is and AGEXTIM tablets are not Bioequivalent and are therefore not substituted on a miligram per miligram basis.</p>\r\n\r\n<p>A careful inquire is recommended before Cefuroxime Axetil therapy is instituted. It is needed to determine if the patient has had previous hyper-sensitivity reactions to Cefuroxime Axetil products, other Cephalosporins, Penicilllins, or other drugs</p>\r\n\r\n<p>Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including Cefuroxime Axetil, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile.</p>\r\n\r\n<p>C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over 2 months after the administration of antibacterial agents.</p>\r\n\r\n<p>If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.</p>\r\n\r\n<p>Prolonged administration of AGEXTIM may result in overgrowth of nonsusceptible microorganisms. If superinfection occurs during therapy, appropriate measures should be taken.</p>\r\n\r\n<p>AGEXTIM should be given with caution to patients receiving concurrent treatment with potent diuretics because these diuretics are suspected of adversely affecting renal function.</p>\r\n\r\n<p>AGEXTIM should be prescribed with caution in individuals with a history of colitis. The safety and effectiveness of AGEXTIM have not been established in patients with gastrointestinal malabsorption.</p>\r\n\r\n<p>Cephalosporins may be associated with a fall in prothrombin activity. Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. Prothrombin time should be monitored in patients at risk and exogenous Vitamin K administered as indicated.</p>\r\n\r\n<p>Prescribing AGEXTIM in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.<br />\r\nNursing Mothers: Because cefuroxime is excreted in human milk, consideration should be given to discontinuing nursing temporarily during treatment with Cefuroxime Axetil.</p>\r\n\r\n<p><strong>Drug Interactions</strong></p>\r\n\r\n<p>Concomitant administration of probenecid with Cefuroxime Axetil increases the area under the serum concentration versus time curve by 50%. The peak serum cefuroxime concentration after a 1.5 g single dose is greater when taken with 1 g of probenecid (mean = 14.8 mcg/mL) than without probenecid (mean = 12.2 mcg/mL).</p>\r\n\r\n<p>Drugs that reduce gastric acidity may result in a lower bioavailability of Cefuroxime Axetil tablets compared with that of fasting state and tend to cancel the effect of postprandial absorption.<br />\r\nIn common with other antibiotics, Cefuroxime Axetil may affect the gut flora, leading to lower estrogen reabsorption and reduced efficacy of combined oral estrogen/ progesterone contraceptives.</p>\r\n\r\n<p>In common with other antibiotics, Cefuroxime Axetil may affect the gut flora, leading to lower estrogen reabsorption and reduced efficacy of combined oral estrogen/ progesterone contraceptives.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>Children (Pediatric Use)</p>\r\n\r\n<p>Otitis Media: 3 months to 12 years: 250 mg tablet orally twice a day for 10 days or 15 mg/kg of the suspension twice a day for 10 days; maximum daily dose is 1000 mg Sinusitis: 3 months to 12 years: 250 mg tablet orally twice a day for 10 days or 15 mg/kg of the suspension orally twice a day for 10 to 14 days; maximum daily dose is 1000 mg 13 years or older: Adult dose Skin and Structure Infection: 3 months to 12 years: 15 mg/kg of the suspension orally twice a day for 10 days; maximum daily dose is 1000 mg Impetigo: 3 months to 12 years: 15 mg/kg of the suspension orally twice a day for 10 days; maximum daily dose is 1000 mg Tonsillitis/Pharyngitis: 3 months to 12 years: 10 mg/kg of the suspension twice a day for 10 days; maximum daily dose is 500 mg 13 years or older: Adult dose Bacterial Infection: 3 months to 12 years: Suspension: 10 to 15 mg/kg orally twice a day (maximum dose 1000 mg/day). Tablets: 250 mg orally twice a day 13 years or older: Adult dose</p>\r\n\r\n<p><strong>Presentation</strong><br />\r\nAGEXTIM DRY SYRUP: 30 mL Bottle of Oral Suspension with Distilled Water</p>\r\n', '125', '', 1, 0, 0, '', '', '', '', '', '9911.jpg', '', '', '', '', '', '2021-11-17 07:06:15', '<p>Cefuroxime Axetil 125 mg for Oral Suspension</p>\r\n\r\n<p><strong>Compositions</strong><br />\r\nEach 5 ml of reconstituted suspension of AGEXTIM Suspension contains<br />\r\nCefuroxime as Cefuroxime Axetil IP...125 mg</p>\r\n'),
(57, '34', '', 'Agextrone Soft Gel', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '3469.jpg', '', '', '', '', '', '2021-11-17 07:08:50', ''),
(58, '30', '', 'Agex-TZ 562.5', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '22892.jpg', '', '', '', '', '', '2021-11-17 07:10:12', ''),
(59, '30', '', 'Agex-TZ 1125', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '11061.jpg', '', '', '', '', '', '2021-11-17 07:11:20', ''),
(60, '2', '', 'Agifix-50 Dry Syrup', '', '', 0, '<p><strong>Therapeutic Indications &amp; Usage</strong></p>\r\n\r\n<p>AGIFIX-50 (Cefixime 50 mg) Dry Syrup from Agex Laboratories is indicated for the treatment of infections caused by susceptible bacteria:<br />\r\n&bull; Upper respiratory tract infections, such as pharyngitis, sinusitis, otitis media, tonsillitis.<br />\r\n&bull; Lower respiratory tract infections, such as acute bronchitis and acute exacerbation of chronic bronchitis.<br />\r\n&bull; Uncomplicated urinary tract infections.<br />\r\n&bull; Uncomplicated gonorrhea.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>AGIFIX-50 (Cefixime-50 mg) Dry Syrup is not advocated for those with a history of hypersensitivity to beta-lactams, e.g. penicillins and cephalosporins.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>AGIFIX-50 (Cefixime-50 mg) Dry Syrup should be advocated with caution in presence of renal impairment or GI disease, particularly colitis. Prolonged use of AGIFIX-50 could result in overgrowth of non-susceptible organisms. If superinfections occur (usually involving Aerobacter, Pseudomonas or Candida spp), AGIFIX-50 should be discontinued and/or appropriate therapy instituted.</p>\r\n\r\n<p>Periodic assessment of hematopoietic function is advisable during prolonged AGIFIX therapy. Safety and efficacy of cefixime in children less than 6 months old have not been established.</p>\r\n\r\n<p>AGIFIX-50 (Cefixime 50 mg) Dry Syrup must be coadministered with carbamazepine, warfarin and other anticoagulants.</p>\r\n\r\n<p><strong>Adverse Reactions</strong></p>\r\n\r\n<p>The most frequent adverse effect is gastrointestinal (GI) complaints, and diarrhea incidence is 16%. Other side effects include hypersensitivity reactions, liver / renal dysfunction, headaches, dizziness, seizures, hematopoietic changes, genital pruritus, vaginitis, candidiasis.</p>\r\n\r\n<p><strong>Drug Interaction</strong></p>\r\n\r\n<p>Elevated carbamazepine levels occur when cefixime AGIFIX is coadministered. When given with warfarin / anticoagulants, the prothrombin time is elevated. Probenecid can decrease its clearance, whilst cholestyramine diminishes absorption of paracetamol when coadministered.</p>\r\n\r\n<p><strong>Recommended Dosage &amp; Administration</strong></p>\r\n\r\n<p>Children<br />\r\n&lt;50 kg: 8 mg/kg/day of AGIFIX Suspension / AGIFIX 50 / 100 DT either as single dose or in two divided doses. &gt;50 kg:</p>\r\n\r\n<p><strong>Presentation</strong><br />\r\nAGIFIX 50: 30 ml bottle with measuring cap</p>\r\n', '44.30', '', 1, 0, 0, '', '', '', '', '', '12603.jpg', '', '', 'Add', '', '', '2021-11-17 12:18:11', '<p>Cefixime 50 mg for Oral Suspension</p>\r\n\r\n<p><strong>Composition</strong></p>\r\n\r\n<p>Each 5 ml of reconstituted AGIFIX Dry Syrup contains:<br />\r\nCefixime trihydrate Equivalent to anhydrous cefixime &hellip; 50 mg</p>\r\n'),
(61, '2', '', 'Agifix-200 Tablets', '', '', 0, '<p><strong>Indications</strong></p>\r\n\r\n<p>AGIFIX-200 from Agex Laboratories is indicated for the treatment of infections caused by susceptible bacteria:</p>\r\n\r\n<ul>\r\n	<li>Upper respiratory tract infections, such as pharyngitis, sinusitis, otitis media, tonsillitis.</li>\r\n	<li>Lower respiratory tract infections, such as acute bronchitis and acute exacerbation of chronic bronchitis.</li>\r\n	<li>Uncomplicated urinary tract infections.</li>\r\n	<li>Uncomplicated gonorrhea.</li>\r\n</ul>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>AGIFIX-200 from Agex Laboratories is not advocated for those with a history of hypersensitivity to beta-lactams, e.g. penicillins and cephalosporins.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>AGIFIX-200 Tablets should be advocated with caution in presence of renal impairment or GI disease, particularly colitis. Prolonged use of AGIFIX-200 Tablets could result in overgrowth of non-susceptible organisms. If superinfections occur (usually involving Aerobacter, Pseudomonas or Candida spp), AGIFIX-200 Tablets should be discontinued and/or appropriate therapy instituted.</p>\r\n\r\n<p>Periodic assessment of hematopoietic function is advisable during prolonged AGIFIX therapy. AGIFIX is not ideally meant for pregnant lady or lactating mother; however, it could be only if strictly necessary. Nursing discontinuation temporarily must be considered whilst taking AGIFIX. Safety and efficacy of cefixime in children less than 6 months old have not been established.</p>\r\n\r\n<p>AGIFIX-200 must be coadministered with carbamazepine, warfarin and other anticoagulants.</p>\r\n\r\n<p><strong>Adverse Reactions</strong></p>\r\n\r\n<p>The most frequent adverse effect is gastrointestinal (GI) complaints, and diarrhea incidence is 16%. Other side effects include hypersensitivity reactions, liver / renal dysfunction, headaches, dizziness, seizures, hematopoietic changes, genital pruritus, vaginitis, candidiasis.</p>\r\n\r\n<p><strong>Drug Interaction</strong></p>\r\n\r\n<p>Elevated carbamazepine levels occur when cefixime (AGIFIX) is coadministered. When given with warfarin / anticoagulants, the prothrombin time is elevated. Probenecid can decrease its clearance, whilst cholestyramine diminishes absorption of paracetamol when coadministered.</p>\r\n\r\n<p><strong>Recommended Dosage &amp; Administration</strong></p>\r\n\r\n<p>Adults Susceptible infections: 1 AGIFIX 200 Tab or 2 AGIFIX Tabs OD, or as prescribed. Uncomplicated cervical / urethral gonococcal infections: 2 AGIFIX Tabs, or as prescribed.</p>\r\n\r\n<p><strong>Presentation</strong></p>\r\n\r\n<p>AGIFIX-200 Tablets: Alu Alu strips of 10s.</p>\r\n', '89.00', '', 1, 0, 0, '', '', '', '', '', '3477.jpg', '', '', 'Add', '', '', '2021-11-17 12:18:13', '<p>Cefixime 200 mg Tablets</p>\r\n\r\n<p><strong>Composition</strong></p>\r\n\r\n<p>Each dispersible tablet of AGIFIX-200 contains:<br />\r\nCefixime trihydrate Equivalent to anhydrous cefixime &hellip; 200 mg</p>\r\n'),
(62, '2', '', 'Agifix-CV Tab', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '24234.jpg', '', '', 'Add', '', '', '2021-11-17 12:18:15', ''),
(63, '2', '', 'AGIFIX-OX Tablets', '', '', 0, '<p><strong>Therapeutic Indications &amp; Usage</strong></p>\r\n\r\n<p>AGIFIX-OX (Cefixime 200 mg &amp; Ofloxacin 200 mg) Tablet from Agex Laboratories is indicated for multi-drug resistant typhoid, Urinary tract infections &amp; pyrexia of unknown origin (PUO).</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>AGIFIX-OX is not advocated for those with a history of hypersensitivity to beta-lactams, e.g. penicillins &amp; cephalosporins. Pregnant women and breast-feeding mothers should initiate therapy upon doctor&#39;s consultation. Dosage modification is advised in patients with renal impairment.</p>\r\n\r\n<p><strong>Adverse Reactions</strong></p>\r\n\r\n<p>Abdominal pain, nausea, vomiting, dyspepsia, flatulence, loose stools, diarrhea, anaphylaxis, and rarelyseizures.</p>\r\n\r\n<p><strong>Recommended Dosage &amp; Administration</strong></p>\r\n\r\n<p>1 tablet twice a day for 7 - 14 days or as directed by the Physician</p>\r\n\r\n<p><strong>Presentations</strong></p>\r\n\r\n<p>AGIFIX OX &ndash; Alu Alu of 10 tablets.</p>\r\n', '104.00', '', 1, 0, 0, '', '', '', '', '', '19099.jpg', '', '', '', '', '', '2021-11-17 07:24:58', '<p>Cefixime 200 mg &amp; Olfoxacin 200 mg Tablets</p>\r\n\r\n<p><strong>Composition</strong><br />\r\nEach film coated tablet of AGIFIX &ndash; OX contains:<br />\r\nCefixime IP as Trihydrate equivalent to Anhydrous&hellip; 200 mg<br />\r\nOfloxacin&hellip;.................................................................200 mg</p>\r\n'),
(64, '35', '', 'Agilin-P', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '22795.jpg', '', '', '', '', '', '2021-11-17 07:29:46', ''),
(65, '35', '', 'Agin-5 TABLETS', '', '', 0, '<p><strong>Indications</strong></p>\r\n\r\n<p>Year-round (perennial) allergies in adults and children who are at least 6 months old. Seasonal allergies in adults and children who are at least 2 years old. Itching and swelling caused by chronic urticaria (hives) in adults and children who are at least 6 months old.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>End-stage kidney disease or dialysis. Liver disease Urination problems (caused by conditions such as enlarged prostate or spinal cord lesion) Gallbladder problems.</p>\r\n\r\n<p><strong>Drug Interactions</strong><br />\r\nAGIN-5 (Levocetirizine 5 mg) Tablets may interact with a sleeping pill, narcotic pain medicine, muscle relaxer, or medicine for anxiety, depression, or seizures. Special precautions need to be taken with Ritonavir or theophylline</p>\r\n\r\n<p><strong>Dosage</strong></p>\r\n\r\n<p>Usual Adult Dose for Allergic Rhinitis: 5 mg orally once daily in the evening Usual Adult Dose for Urticaria: 5 mg orally once daily in the evening.&nbsp;Usual Pediatric Dose for Allergic Rhinitis: 12 years or older: 5 mg orally once daily in the evening 6 to 11 years old: 2.5 mg orally once daily in the evening 2 to 5 years old: 1.25 mg orally once daily in the evening</p>\r\n\r\n<p>Perennial allergic rhinitis and chronic idiopathic urticaria: 12 years or older: 5 mg orally once daily in the evening 6 to 11 years old: 2.5 mg orally once daily in the evening 6 months to 5 years old: 1.25 mg orally once daily in the evening</p>\r\n\r\n<p>Usual Pediatric Dose for Urticaria: Seasonal allergic rhinitis: 12 years or older: 5 mg orally once daily in the evening 6 to 11 years old: 2.5 mg orally once daily in the evening 2 to 5 years old: 1.25 mg orally once daily in the evening</p>\r\n\r\n<p>Perennial allergic rhinitis and chronic idiopathic urticaria: 12 years or older: 5 mg orally once daily in the evening 6 to 11 years old: 2.5 mg orally once daily in the evening 6 months to 5 years old: 1.25 mg orally once daily in the evening</p>\r\n\r\n<p><strong>Presentation</strong><br />\r\nAGIN-5: Blister of 10s</p>\r\n', '35.00', '', 1, 0, 0, '', '', '', '', '', '9751.jpg', '', '', '', '', '', '2021-11-17 07:36:37', '<p>Levocetirizine 5 mg Tablets</p>\r\n\r\n<p><strong>Composition</strong><br />\r\nEach tablet of AGIN-5 Tablet contains:<br />\r\nLevocetirizine.....5 mg</p>\r\n'),
(66, '36', '', 'Agither Inj.', '', '', 0, '<p><strong>Indications</strong></p>\r\n\r\n<p>Acute Malaria</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>AGITHER (Alpha-Beta Arteetheer) injection is contraindicated during pregnancy and lactation</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Safety of AGITHER (Alpha-Beta Arteetheer) injection during Pregnancy is not established.<br />\r\nThe World Health Organization currently advises against the use of artemisinins in the first trimester of pregnancy, unless in a lifesaving situation where other drugs are not suitable. In the second and third trimesters of pregnancy, artemisinin and its derivatives are not recommended unless alternative drug treatments are unsuitable. &nbsp;&nbsp;</p>\r\n\r\n<p><strong>Adverse Reactions</strong></p>\r\n\r\n<p>Nausea, cough and dizziness. Body ache, general weakness, vomiting, pain at inj site, abdominal pain, leg pain, chills and rigors and watery diarrhoea.</p>\r\n\r\n<p><strong>Drug Interaction</strong></p>\r\n\r\n<p>Avoid using with drugs that prolong QT interval</p>\r\n\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<br />\r\n<strong>Dosage</strong></p>\r\n\r\n<p>I.V or I.M . Administration Adults: One ampoule of 150 mg /day for three days Chidren:Not recommended</p>\r\n\r\n<p><strong>Presentations</strong></p>\r\n\r\n<p>AGITHER (Alpha-Beta Arteetheer) injection: Three ampoule pack.</p>\r\n', '250', '', 1, 0, 0, '', '', '', '', '', '31463.jpg', '', '', '', '', '', '2021-11-17 07:42:27', '<p>Alpha-beta Arteether injection</p>\r\n\r\n<p><strong>Composition</strong><br />\r\nEach 2ml AGITHER injection contains:<br />\r\nAlpha-beta Arteether injection&hellip;&hellip;150 mg</p>\r\n'),
(67, '36', '', 'AGITHER - L  Syrup', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '26260.jpg', '', '', '', '', '', '2021-11-17 07:44:47', ''),
(68, '36', '', 'AGITHER - L Tablets', '', '', 0, '<p><strong>Indications</strong><br />\r\nUncomplicated P. falciparum malaria<br />\r\nResistant P. vivax infections<br />\r\nMixed, alarial infections</p>\r\n\r\n<p><strong>Contraindications</strong><br />\r\nHypersensitivity to artemether, lumefantrine, or any ingredient in the formulations.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>QT interval prolongation reported. Do not use in patients with congenital long QT syndrome, clinical conditions known to prolong the QTc interval (e.g., symptomatic cardiac arrhythmias, clinically important bradycardia, severe cardiac disease), family history of congenital long QT syndrome or sudden death, or in those with electrolyte abnormalities (e.g., hypokalemia, hypomagnesemia) Do not use in those receiving treatment with class IA or III antiarrhythmic agents, antipsychotics (e.g., pimozide, ziprasidone), antidepressants, certain anti-infectives (e.g., macrolides, fluoroquinolones, imidazole- or triazole-derivative antifungal agents), cisapride (available in the US only under a limited-use protocol), or drugs known to be CYP2D6 substrates with cardiac effects</p>\r\n\r\n<p><strong>Drug Interactions</strong></p>\r\n\r\n<p>Concomitant use with certain drugs requires particular caution (e.g., other antimalarial drugs, antiretroviral agents).</p>\r\n\r\n<p><strong>Dosage</strong></p>\r\n\r\n<p>Adults:&gt;16 years of age and weighing ?35 kg: 4 tablets as initial dose, 4 tablets 8 hours after the initial dose, and then 4 tablets twice daily (morning and evening) for the next two days .</p>\r\n\r\n<p><strong>Presentations</strong></p>\r\n\r\n<p>AGITHER-L Tablets: Alu Alu of 6s</p>\r\n', '141.00', '', 1, 0, 0, '', '', '', '', '', '30013.jpg', '', '', '', '', '', '2021-11-17 07:47:24', '<p>Artemether 40 mg &amp; Lumefantrine 480 mg Tablets</p>\r\n\r\n<p><strong>Composition</strong><br />\r\nEach tablet of AGITHER-L Tablet contains:<br />\r\nArtemether..............80 mg<br />\r\nLumefantrine...........480 mg &nbsp;</p>\r\n'),
(69, '37', '', 'Agrezyme 100 ML', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '6137.jpg', '', '', '', '', '', '2021-11-17 07:50:32', ''),
(70, '37', '', 'Agrezyme 200 ML', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '17214.jpg', '', '', '', '', '', '2021-11-17 07:51:24', ''),
(71, '38', '', 'Amozox', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '15029.jpg', '', '', '', '', '', '2021-11-17 07:53:30', ''),
(72, '39', '', 'ARTEX-60 INJ', '', '', 0, '', '', '', 1, 0, 0, '', '', '', '', '', '19761.jpg', '', '', '', '', '', '2021-11-17 07:55:31', '');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_product_range`
--

CREATE TABLE `tbl_product_range` (
  `id` int(11) NOT NULL,
  `product_name` varchar(255) NOT NULL,
  `product_title` varchar(255) NOT NULL,
  `brand` varchar(255) NOT NULL,
  `desc1` text NOT NULL,
  `desc2` text NOT NULL,
  `image` varchar(255) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_product_range`
--

INSERT INTO `tbl_product_range` (`id`, `product_name`, `product_title`, `brand`, `desc1`, `desc2`, `image`) VALUES
(11, 'LATEX SURGICAL GLOVES', 'PRE POWDERED', 'Oxyflow', '<h3>Quality Standards</h3>\r\n\r\n<ul>\r\n	<li>\r\n	<p>&nbsp;Manufactured under GMP, EN ISO 13485: and ISO 9001:2008 Quality &nbsp;System.</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Conforms to ASTM D3577 and EN455 standards</p>\r\n	</li>\r\n</ul>\r\n', '<h3>Description</h3>\r\n\r\n<ul>\r\n	<li>\r\n	<p>&nbsp;Gloves compounded primarily from natural&nbsp; rubber latex (Type-1).</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Creamy white to pale yellow in colour</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Free from dirt marks, oil stains, embedded&nbsp;foreign particles, coagula etc.</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Sterile anatomically shaped medical gloves with the thumb positioned towards the palmer surface of the index finger rather&nbsp;than laying fat.</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;The inside and outside of the natural rubber&nbsp;surgical gloves shall be free of talc.</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Sterile gloves for single use only.</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Keep the gloves in cool, dry place away from&nbsp;direct sunlight.</p>\r\n	</li>\r\n</ul>\r\n', '1552454156_pro6.jpg'),
(12, 'CENTRAL VENOUS CATHETER', 'STANDARD KIT', ' Oxyflow', '<h3>Main Content</h3>\r\n\r\n<ul>\r\n	<li>\r\n	<p>&nbsp;Central Venous Catheter</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Guide-wire</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Vessel Dilator</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Clamp</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Fastener: Catheter Clamp</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Introducer Needle</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Introducer Syringe</p>\r\n	</li>\r\n</ul>\r\n', '<table>\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"8\" style=\"vertical-align:top\">\r\n			<h3 style=\"text-align: center;\">PRODUCT SPECIFICATION</h3>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">\r\n			<p>S.No</p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">\r\n			<p>Lumen Size</p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">\r\n			<p>Catheter Size</p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">\r\n			<p>Catheter Length</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">1</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">Single</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">14/16/18/20/22 Gauge</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">5/6/8/10/13/15/16/20 cm</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">2</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">Double</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">4/5/7/8/8.5 Fr.</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">5/6/8/10/13/15/16/20 cm</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">3</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">Triple</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">4.5/5.5/7/8.5 Fr.</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">5/6/8/10/13/15/16/20cm</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">4</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">Quad</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">8.5 Fr.</td>\r\n			<td colspan=\"2\" style=\"vertical-align:top\">5/6/8/10/13/15/16/20cm</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n', '1552454177_pro7.jpg'),
(13, 'CENTRAL VENOUS CATHETER', 'STANDARD KIT', '', '<h3>Main Content</h3>\r\n\r\n<ul>\r\n	<li>\r\n	<p>&nbsp;Central Venous Catheter</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Guide-wire</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Vessel Dilator</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Clamp</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Fastener: Catheter Clamp</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Introducer Needle</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Introducer Syringe</p>\r\n	</li>\r\n</ul>\r\n', '', '1552460894_Untitled-1.jpg'),
(14, 'CENTRAL VENOUS CATHETER', 'STANDARD KIT', '', '<h3>Main Content</h3>\r\n\r\n<ul>\r\n	<li>\r\n	<p>&nbsp;Central Venous Catheter</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Guide-wire</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Vessel Dilator</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Clamp</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Fastener: Catheter Clamp</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Introducer Needle</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Introducer Syringe</p>\r\n	</li>\r\n</ul>\r\n', '', '1552460901_Untitled-1.jpg'),
(15, 'CENTRAL VENOUS CATHETER', 'STANDARD KIT', '', '<h3>Main Content</h3>\r\n\r\n<ul>\r\n	<li>\r\n	<p>&nbsp;Central Venous Catheter</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Guide-wire</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Vessel Dilator</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Clamp</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Fastener: Catheter Clamp</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Introducer Needle</p>\r\n	</li>\r\n	<li>\r\n	<p>&nbsp;Introducer Syringe</p>\r\n	</li>\r\n</ul>\r\n', '', '1552460908_Untitled-1.jpg');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_pro_home`
--

CREATE TABLE `tbl_pro_home` (
  `pro_id` int(11) NOT NULL,
  `project_name` varchar(100) NOT NULL,
  `project_name_two` varchar(100) NOT NULL,
  `project_image` varchar(100) NOT NULL,
  `project_avtive` enum('Yes','No') NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

-- --------------------------------------------------------

--
-- Table structure for table `tbl_service_home`
--

CREATE TABLE `tbl_service_home` (
  `ser_id` int(11) NOT NULL,
  `title_ser1` varchar(200) NOT NULL,
  `title_ser2` varchar(200) NOT NULL,
  `title_ser3` varchar(200) NOT NULL,
  `desc_ser1` text NOT NULL,
  `desc_ser2` text NOT NULL,
  `desc_ser3` text NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_service_home`
--

INSERT INTO `tbl_service_home` (`ser_id`, `title_ser1`, `title_ser2`, `title_ser3`, `desc_ser1`, `desc_ser2`, `desc_ser3`) VALUES
(6, 'Cut to Length', 'Special Packaging', 'Regional Delivery', '<p><strong>Precision</strong> cutting to any length desired is our specialty. Straight off our tube mills we run a Haven 873 cutoff machine, which gives us the flexibility and precision to bring you top quality tubing exactly to specification.</p>\r\n\r\n<p><strong>Precision</strong> cutting to any length desired is our specialty. Straight off our tube mills we run a Haven 873 cutoff machine, which gives us the flexibility and precision to bring you top quality tubing exactly to specification.</p>\r\n', '<p>Sometimes special circumstances require special packaging. RTF can package your steel tubing order to meet your specifications.</p>\r\n', '<p>Ask your Steel Tube Inc. Sales representative about our in- house delivery service. We run our own fleet of trucks for deliveries throughout India.</p>\r\n');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_slider`
--

CREATE TABLE `tbl_slider` (
  `id` int(11) NOT NULL,
  `p_id` int(11) NOT NULL,
  `slider_image` varchar(200) NOT NULL,
  `slider_name` varchar(250) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_slider`
--

INSERT INTO `tbl_slider` (`id`, `p_id`, `slider_image`, `slider_name`) VALUES
(1, 50, '1562155570_pro7.jpg', ''),
(2, 50, '1562155576_pro6.jpg', ''),
(3, 50, '1562155637_pro1.jpg', '');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_social_media`
--

CREATE TABLE `tbl_social_media` (
  `social_id` int(11) NOT NULL,
  `fb_add` varchar(220) NOT NULL,
  `twitter_add` varchar(220) NOT NULL,
  `google_add` varchar(220) NOT NULL,
  `linkdn_add` varchar(220) NOT NULL,
  `sovial_active` enum('Yes','No') NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_social_media`
--

INSERT INTO `tbl_social_media` (`social_id`, `fb_add`, `twitter_add`, `google_add`, `linkdn_add`, `sovial_active`) VALUES
(1, 'facebook', 'twitter', 'google', 'linked in', '');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_stativ_pages`
--

CREATE TABLE `tbl_stativ_pages` (
  `id` int(11) NOT NULL,
  `page_name` varchar(300) NOT NULL,
  `about_text_image` varchar(400) NOT NULL,
  `introduction` text NOT NULL,
  `footer_desc` text NOT NULL,
  `add_certificate` varchar(200) NOT NULL,
  `logo_certificate` varchar(255) NOT NULL,
  `intro_title` text NOT NULL,
  `connectivity_acheivement` text NOT NULL,
  `estab_title` varchar(100) NOT NULL,
  `unit` text NOT NULL,
  `unit_title` varchar(100) NOT NULL,
  `desc_one` text NOT NULL,
  `desc_two` text NOT NULL,
  `desc_three` text NOT NULL,
  `desc_four` text NOT NULL,
  `desc_five` varchar(500) NOT NULL,
  `title_one` varchar(200) NOT NULL,
  `title_two` varchar(200) NOT NULL,
  `title_three` varchar(200) NOT NULL,
  `title_four` varchar(200) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_stativ_pages`
--

INSERT INTO `tbl_stativ_pages` (`id`, `page_name`, `about_text_image`, `introduction`, `footer_desc`, `add_certificate`, `logo_certificate`, `intro_title`, `connectivity_acheivement`, `estab_title`, `unit`, `unit_title`, `desc_one`, `desc_two`, `desc_three`, `desc_four`, `desc_five`, `title_one`, `title_two`, `title_three`, `title_four`) VALUES
(3, '', '', '<h2>Who We Are</h2>\r\n\r\n<h3>WELCOME TO AGEX LABORATORIES PVT. LTD.</h3>\r\n\r\n<p>Agex Laboratories is one of the leading pharmaceutical companies in India with a closely knit chain of a strong team of pharmaceutical professionals, distributors, and retailers. Headquartered in Gurugram, Haryana, Agex Laboratories Pvt. Ltd. has started off in 2014 and within a short span of three years the company has set up its operations in over 240 districts of India.&nbsp;At Agex, our emphasis on quality, innovation, and affordable solutions in medicine makes us one of the significant players in the Indian pharmaceutical market. Our prescription medicines range across therapeutic areas such as antibiotics, anti-malarial, analgesic, anti-inflammatory, gastrointestinal, gynaecological, and respiratory diseases. We also offer a range of nutritional products, including multi-vitamins, energy supplements, and food supplements.</p>\r\n', '<p>We would like to introduce ourselves as a leading company of construction equipments. Shiv Enterprises was established in 2013 by Mr. Lokesh Who is the founder of the company.</p>\r\n', '5090RASHTRIYA STAINLESS STEEL.jpg', '22770new-icon.png', 'Aesop was one of the great Greek writers He is the best known for his fabl;es Aesop was one of the great Greek writers He is the best.', '', '', '', '', '<p>At Agex, we are committed to increasing the longevity of individuals and enabling them to live healthy and better life. And we make this possible by offering effective health care solutions. Our aim is to become a leading, global research-based pharmaceutical company.</p>\r\n\r\n<p>Our business strategy enables us to deliver quality and cost-effective medicines to masses largely living in unserved and underserved areas of the country. We partner with others to provide quality and cost effective health care solutions as well as a range of treatment options for healthcare professionals and patients. Collaboration is the core of our strategy. It enables us to understand the needs of patients and the practitioners for our continued success. We work closely with our partners to get the insights into delivering medicines that make the difference in healthcare.</p>\r\n', 'We will take the advanced management and the idea of daring to innovate as the core power of our company, and will provide high quality, practical, reliable pipe fittings and flanges to our users.', 'We are a Stockist and Exporter of Nuts, Bolts, Screws, Washers and Studs in many different grades to the many application industry like oil & gas, chemical industry, petrochemical industry, Power and Process Industries etc.', 'om the very first stage of procurement of raw materials to the final dispatch, our products are timely altered according to ASTM requirements, assuring international quality standards. We assure you of our best Quality and Services.', 'We manufacture in accordance with the applicable standards, with data sheets or individual specification. Small batches to complete shutdown requirements can be manufactured. Our testing equipment and our highly skilled personnel ensure the high standard of our products.', 'Reliable Company', 'Quality Assurance', 'Huge Inventory', 'Global Resources With Local Support'),
(4, '', '', '<h2>Work Environment</h2>\r\n\r\n<h3>People &amp; Culture</h3>\r\n\r\n<p>Agex Laboratories is managed by an experienced management team committed to developing the organization in the various market segments of the Pharmaceutical industry.</p>\r\n\r\n<p>Doing things differently is the DNA of Agex Laboratories. We empower our people and minimize control in day-to-day activities of the business, and this is what maximizes individual&rsquo;s performance and success at Agex Laboratories. Our emphasis on collaboration and an environment that nurtures creativity at work has helped us achieve excellence in deep market penetration and product deliveries.</p>\r\n', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', ''),
(5, '', '', '<h2>Good Reasons</h2>\r\n\r\n<h3>Why Choose Us</h3>\r\n\r\n<p><strong>One of the Fastest Growing Pharmaceutical Companies</strong></p>\r\n\r\n<p>Agex Laboratories is one of the fastest growing companies in India. Our prime focus is no on delivering affordable and accessible medicines to meet community needs. Within a short time period, we have set up and rolled out our operations successfully in over 240 districts in India. Presently, Agex Laboratories has over 200 product formulations in various pharmaceutical categories, including anti-biotics, gastrointestinal, gynecological, and orthopedic &amp; pain management. Agex Laboratories is also planning to foray into diabetic and cardiac segments.</p>\r\n\r\n<p><strong>Reach and Affordability</strong></p>\r\n\r\n<p>Agex Laboratories complies with all applicable legislation and regulations as well as adheres to good distribution and storage practices to ensure the original quality of pharmaceutical products. All pharmaceutical products of Agex Laboratories are manufactured at state-of-the-art facilities which are designed to comply with c-GMP and WHO-GMP certification norms. Manufacturing units have controlled temperature and relative humidity environment in warehouse. At Agex Laboratories, we make sure that goods are shipped in clean and secured vehicles. &nbsp;Central warehouse at Agex has separate storage sections to accommodate and preserve goods.</p>\r\n\r\n<p><strong>Geographical Presence</strong></p>\r\n\r\n<p>Agex Laboratories makes sure that its products reach throughout India.</p>\r\n\r\n<ul>\r\n	<li>5 Regions</li>\r\n	<li>20 States in 5 Regions</li>\r\n</ul>\r\n\r\n<p><strong>Product Portfolio</strong></p>\r\n\r\n<p>Agex Laboratories has over 200 products in different therapeutic segments &ndash; anti-biotics, orthopedic &amp; pain management, PPI &amp; gastrointestinal, gynecological, pediatrics, anti-malarials, anti-fungal &amp; dermatological, hormonal, and neutraceuticals. Agex Laboratories has plans to add new molecules as well.</p>\r\n\r\n<p>Stringent Quality Norms</p>\r\n\r\n<p>Agex Laboratories Pvt. Ltd. is in tune with the current manufacturing trends in healthcare industry. Our all products are manufactured in WHO-GMP compliant plants which are in compliance with major regulatory bodies.</p>\r\n', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', ''),
(6, '', '', '<h2>Intentions &amp; Directions</h2>\r\n\r\n<h3>Our Process &amp; Policy</h3>\r\n\r\n<p>Agex Laboratories Pvt. Ltd. is in tune with the current manufacturing trends in pharmaceutical industry. Our all products are manufactured in WHO-GMP compliant plants which are in compliance with major regulatory bodies. Being in the business of pharmaceutical products, Agex Laboratories acknowledges quality as the first and the foremost important aspect. At Agex Laboratories, we ensure that manufacturing units must have following key ingredients of manufacturing process:</p>\r\n\r\n<ul>\r\n	<li>Exhaustive Specifications for Inputs &amp; Outputs</li>\r\n	<li>Stringent In-process Controls</li>\r\n	<li>Independent Quality Assurance Department</li>\r\n	<li>&nbsp;Elaborate Standard Operating Procedures</li>\r\n</ul>\r\n\r\n<p><strong>Quality Policy</strong></p>\r\n\r\n<ul>\r\n	<li>To satisfy the needs and expectations of customers.</li>\r\n	<li>To deliver quality at each and every level.</li>\r\n	<li>To assure commitment to safety and efficacy</li>\r\n	<li>To engage employees for continuous improvement</li>\r\n</ul>\r\n', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', ''),
(7, '', '', '<h2>Quality Assurance</h2>\r\n\r\n<h3>Systematic Processing</h3>\r\n\r\n<p>Agex Laboratories has a very well structured Quality Management System (QMS) that ensures excellence in product delivery to patients. Our QMS has also enabled us to strengthen the practice of sharing and collaboration across the organization.</p>\r\n\r\n<p>The QMS at Agex Laboratories is dedicated to process development, product manufacturing and distribution of products. It also ensures safety, efficacy and compliance of customer and government regulations. &nbsp;Agex Laboratories employs an independent, third party Quality Control Laboratory for the annual review of product quality. The key components of the QMS in Agex are resource management, employee training, quality and compliance data trending.</p>\r\n\r\n<p>Agex Laboratories continuously works to improve upon its QMS through rigorous review as well as audit based on cGxP compliance of the contract manufacturing sites. The Quality Assurance Team ensures Quality Operations through providing necessary resources, technical guidance and training.</p>\r\n\r\n<p>Corporate Quality Assurance provides the necessary resources, technical guidance and training to ensure quality operation. It regularly upgrades skills and competence levels in various functions by introducing advance systems and technology. The Corporate Quality Assurance team regularly conducts audit of all manufacturing sites.</p>\r\n\r\n<p>Our Key Quality system includes:</p>\r\n\r\n<ul>\r\n	<li>Production system</li>\r\n	<li>Facilities and equipment system</li>\r\n	<li>Packing and labelling</li>\r\n	<li>Distribution system</li>\r\n</ul>\r\n\r\n<p>Through our good distribution practices, we ensure that best quality products are delivered to patients and consumers.</p>\r\n', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_subcategory`
--

CREATE TABLE `tbl_subcategory` (
  `id` int(100) NOT NULL,
  `cat_id` int(100) NOT NULL,
  `sub_name` varchar(200) NOT NULL,
  `sub_image` text NOT NULL,
  `stastus` varchar(50) NOT NULL,
  `home_status` varchar(11) NOT NULL,
  `dat` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_subcategory`
--

INSERT INTO `tbl_subcategory` (`id`, `cat_id`, `sub_name`, `sub_image`, `stastus`, `home_status`, `dat`) VALUES
(1, 1, 'Ageclav', '2284.', '', '', '2021-10-30 09:24:30'),
(2, 1, 'Agifix', '29987.', '', '', '2021-10-30 09:24:58'),
(3, 1, 'Agifix-ox', '14880.', '', '', '2021-10-30 09:25:09'),
(5, 1, 'Agifix-cv', '6275.', '', '', '2021-10-30 09:25:19'),
(6, 1, 'Agifix-oz', '2560.', '', '', '2021-10-30 09:25:29'),
(7, 1, 'Agextil', '29241.', '', '', '2021-10-30 09:25:39'),
(8, 2, 'Pantozex', '5723.', '', '', '2021-10-30 09:26:20'),
(9, 2, 'Pantozex - D', '28408.', '', '', '2021-10-30 09:26:31'),
(11, 2, 'Pazenta-dsr', '17964.', '', '', '2021-10-30 09:26:40'),
(12, 2, 'Pazenta', '30965.', '', '', '2021-10-30 09:26:58'),
(13, 2, 'Rabaze', '22154.', '', '', '2021-10-30 09:27:26'),
(14, 2, 'Omex', '5371.', '', '', '2021-10-30 09:27:39'),
(15, 3, 'Rings', '14154.', '', '', '2019-07-27 11:27:06'),
(16, 3, 'Earrings', '18107.', '', '', '2019-07-27 11:27:14'),
(17, 3, 'Pendant', '6424.', '', '', '2019-07-27 11:27:21'),
(18, 3, 'Chains', '12145.', '', '', '2019-07-27 11:27:28'),
(19, 3, 'Nose Pins', '20822.', '', '', '2019-07-27 11:27:38'),
(20, 3, 'Mangalsutra', '2715.', '', '', '2019-07-27 11:41:07'),
(21, 15, 'Lpg', '6798.', '', '', '2021-11-17 04:17:32'),
(22, 1, 'Ageclin', '18979.', '', '', '2021-11-17 05:29:38'),
(24, 16, 'Agecort', '2134.', '', '', '2021-11-17 05:38:57'),
(25, 17, 'Agelax', '9167.', '', '', '2021-11-17 05:50:58'),
(26, 2, 'Ageliv', '11755.', '', '', '2021-11-17 05:54:09'),
(27, 9, 'Agemith', '25109.', '', '', '2021-11-17 05:59:37'),
(28, 17, 'Ageplex', '8989.', '', '', '2021-11-17 06:03:57'),
(29, 17, 'Agerim', '21529.', '', '', '2021-11-17 06:07:31'),
(30, 1, 'Agex', '25474.', '', '', '2021-11-17 06:10:42'),
(31, 1, 'Agexa', '9511.', '', '', '2021-11-17 06:13:37'),
(32, 17, 'Agexee ', '5116.', '', '', '2021-11-17 06:31:14'),
(33, 1, 'Agextim', '26587.', '', '', '2021-11-17 06:54:27'),
(34, 17, 'Agextrone ', '28196.', '', '', '2021-11-17 07:07:46'),
(35, 1, 'Agilin-p', '17841.', '', '', '2021-11-17 07:28:41'),
(36, 8, 'Agither', '29672.', '', '', '2021-11-17 07:38:14'),
(37, 17, 'Agrezyme', '22595.', '', '', '2021-11-17 07:49:14'),
(38, 17, 'Amozox', '13727.', '', '', '2021-11-17 07:52:36'),
(39, 17, 'Artex', '3259.', '', '', '2021-11-17 07:54:39');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_testimonial`
--

CREATE TABLE `tbl_testimonial` (
  `testi_id` int(11) NOT NULL,
  `testi_name` text NOT NULL,
  `testi_desc` text NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_testimonial`
--

INSERT INTO `tbl_testimonial` (`testi_id`, `testi_name`, `testi_desc`) VALUES
(8, 'https://www.youtube.com/embed/Sx_V9ts7Jrk', ''),
(9, 'https://www.youtube.com/embed/Sx_V9ts7Jrk', ''),
(10, 'https://www.youtube.com/embed/Sx_V9ts7Jrk', ''),
(11, 'https://www.youtube.com/embed/Sx_V9ts7Jrk', '');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_web_logo`
--

CREATE TABLE `tbl_web_logo` (
  `logo_id` int(11) NOT NULL,
  `logo_image_name` varchar(255) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_web_logo`
--

INSERT INTO `tbl_web_logo` (`logo_id`, `logo_image_name`) VALUES
(13, '1635582975_logo.png');

-- --------------------------------------------------------

--
-- Table structure for table `tbl_why_us`
--

CREATE TABLE `tbl_why_us` (
  `why_id` int(11) NOT NULL,
  `why_us_description` text NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `tbl_why_us`
--

INSERT INTO `tbl_why_us` (`why_id`, `why_us_description`) VALUES
(1, '<p><strong>Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry&#39;s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n');

--
-- Indexes for dumped tables
--

--
-- Indexes for table `client_logo`
--
ALTER TABLE `client_logo`
  ADD PRIMARY KEY (`client_logo_id`);

--
-- Indexes for table `coins_cate`
--
ALTER TABLE `coins_cate`
  ADD PRIMARY KEY (`cat_id`);

--
-- Indexes for table `coins_product`
--
ALTER TABLE `coins_product`
  ADD PRIMARY KEY (`pro_id`);

--
-- Indexes for table `collection_metal_information`
--
ALTER TABLE `collection_metal_information`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `collection_product_information`
--
ALTER TABLE `collection_product_information`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `gemstone_cate`
--
ALTER TABLE `gemstone_cate`
  ADD PRIMARY KEY (`cat_id`);

--
-- Indexes for table `gemstone_metal_information`
--
ALTER TABLE `gemstone_metal_information`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `gemstone_product`
--
ALTER TABLE `gemstone_product`
  ADD PRIMARY KEY (`pro_id`);

--
-- Indexes for table `gemstone_product_information`
--
ALTER TABLE `gemstone_product_information`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `gemstone_subcate`
--
ALTER TABLE `gemstone_subcate`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `header_flash`
--
ALTER TABLE `header_flash`
  ADD PRIMARY KEY (`header_id`);

--
-- Indexes for table `profmonth`
--
ALTER TABLE `profmonth`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `profweek`
--
ALTER TABLE `profweek`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `shopbymoq`
--
ALTER TABLE `shopbymoq`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `shopbyprice`
--
ALTER TABLE `shopbyprice`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `tbl_about_us`
--
ALTER TABLE `tbl_about_us`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `tbl_add_list`
--
ALTER TABLE `tbl_add_list`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `tbl_banner`
--
ALTER TABLE `tbl_banner`
  ADD PRIMARY KEY (`banner_id`);

--
-- Indexes for table `tbl_blog`
--
ALTER TABLE `tbl_blog`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `tbl_brand`
--
ALTER TABLE `tbl_brand`
  ADD PRIMARY KEY (`brand_id`);

--
-- Indexes for table `tbl_category`
--
ALTER TABLE `tbl_category`
  ADD PRIMARY KEY (`cat_id`);

--
-- Indexes for table `tbl_contact_desc`
--
ALTER TABLE `tbl_contact_desc`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `tbl_footer_logo`
--
ALTER TABLE `tbl_footer_logo`
  ADD PRIMARY KEY (`logo_id`);

--
-- Indexes for table `tbl_home_product`
--
ALTER TABLE `tbl_home_product`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `tbl_legal_desc`
--
ALTER TABLE `tbl_legal_desc`
  ADD PRIMARY KEY (`legl_id`);

--
-- Indexes for table `tbl_news_letter`
--
ALTER TABLE `tbl_news_letter`
  ADD PRIMARY KEY (`news_letter_id`);

--
-- Indexes for table `tbl_product`
--
ALTER TABLE `tbl_product`
  ADD PRIMARY KEY (`pro_id`);

--
-- Indexes for table `tbl_product_range`
--
ALTER TABLE `tbl_product_range`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `tbl_pro_home`
--
ALTER TABLE `tbl_pro_home`
  ADD PRIMARY KEY (`pro_id`);

--
-- Indexes for table `tbl_service_home`
--
ALTER TABLE `tbl_service_home`
  ADD PRIMARY KEY (`ser_id`);

--
-- Indexes for table `tbl_slider`
--
ALTER TABLE `tbl_slider`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `tbl_social_media`
--
ALTER TABLE `tbl_social_media`
  ADD PRIMARY KEY (`social_id`);

--
-- Indexes for table `tbl_stativ_pages`
--
ALTER TABLE `tbl_stativ_pages`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `tbl_subcategory`
--
ALTER TABLE `tbl_subcategory`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `tbl_testimonial`
--
ALTER TABLE `tbl_testimonial`
  ADD PRIMARY KEY (`testi_id`);

--
-- Indexes for table `tbl_web_logo`
--
ALTER TABLE `tbl_web_logo`
  ADD PRIMARY KEY (`logo_id`);

--
-- Indexes for table `tbl_why_us`
--
ALTER TABLE `tbl_why_us`
  ADD PRIMARY KEY (`why_id`);

--
-- AUTO_INCREMENT for dumped tables
--

--
-- AUTO_INCREMENT for table `client_logo`
--
ALTER TABLE `client_logo`
  MODIFY `client_logo_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=52;

--
-- AUTO_INCREMENT for table `coins_cate`
--
ALTER TABLE `coins_cate`
  MODIFY `cat_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=3;

--
-- AUTO_INCREMENT for table `coins_product`
--
ALTER TABLE `coins_product`
  MODIFY `pro_id` int(11) NOT NULL AUTO_INCREMENT;

--
-- AUTO_INCREMENT for table `collection_metal_information`
--
ALTER TABLE `collection_metal_information`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=5;

--
-- AUTO_INCREMENT for table `collection_product_information`
--
ALTER TABLE `collection_product_information`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=3;

--
-- AUTO_INCREMENT for table `gemstone_cate`
--
ALTER TABLE `gemstone_cate`
  MODIFY `cat_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=4;

--
-- AUTO_INCREMENT for table `gemstone_metal_information`
--
ALTER TABLE `gemstone_metal_information`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=5;

--
-- AUTO_INCREMENT for table `gemstone_product`
--
ALTER TABLE `gemstone_product`
  MODIFY `pro_id` int(11) NOT NULL AUTO_INCREMENT;

--
-- AUTO_INCREMENT for table `gemstone_product_information`
--
ALTER TABLE `gemstone_product_information`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=5;

--
-- AUTO_INCREMENT for table `gemstone_subcate`
--
ALTER TABLE `gemstone_subcate`
  MODIFY `id` int(100) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=21;

--
-- AUTO_INCREMENT for table `header_flash`
--
ALTER TABLE `header_flash`
  MODIFY `header_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=58;

--
-- AUTO_INCREMENT for table `profmonth`
--
ALTER TABLE `profmonth`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=15;

--
-- AUTO_INCREMENT for table `profweek`
--
ALTER TABLE `profweek`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=11;

--
-- AUTO_INCREMENT for table `shopbymoq`
--
ALTER TABLE `shopbymoq`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=8;

--
-- AUTO_INCREMENT for table `shopbyprice`
--
ALTER TABLE `shopbyprice`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=10;

--
-- AUTO_INCREMENT for table `tbl_about_us`
--
ALTER TABLE `tbl_about_us`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=2;

--
-- AUTO_INCREMENT for table `tbl_add_list`
--
ALTER TABLE `tbl_add_list`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=3;

--
-- AUTO_INCREMENT for table `tbl_banner`
--
ALTER TABLE `tbl_banner`
  MODIFY `banner_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=25;

--
-- AUTO_INCREMENT for table `tbl_blog`
--
ALTER TABLE `tbl_blog`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=7;

--
-- AUTO_INCREMENT for table `tbl_brand`
--
ALTER TABLE `tbl_brand`
  MODIFY `brand_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=12;

--
-- AUTO_INCREMENT for table `tbl_category`
--
ALTER TABLE `tbl_category`
  MODIFY `cat_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=18;

--
-- AUTO_INCREMENT for table `tbl_contact_desc`
--
ALTER TABLE `tbl_contact_desc`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=2;

--
-- AUTO_INCREMENT for table `tbl_footer_logo`
--
ALTER TABLE `tbl_footer_logo`
  MODIFY `logo_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=3;

--
-- AUTO_INCREMENT for table `tbl_home_product`
--
ALTER TABLE `tbl_home_product`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=3;

--
-- AUTO_INCREMENT for table `tbl_legal_desc`
--
ALTER TABLE `tbl_legal_desc`
  MODIFY `legl_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=2;

--
-- AUTO_INCREMENT for table `tbl_news_letter`
--
ALTER TABLE `tbl_news_letter`
  MODIFY `news_letter_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=13;

--
-- AUTO_INCREMENT for table `tbl_product`
--
ALTER TABLE `tbl_product`
  MODIFY `pro_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=73;

--
-- AUTO_INCREMENT for table `tbl_product_range`
--
ALTER TABLE `tbl_product_range`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=16;

--
-- AUTO_INCREMENT for table `tbl_pro_home`
--
ALTER TABLE `tbl_pro_home`
  MODIFY `pro_id` int(11) NOT NULL AUTO_INCREMENT;

--
-- AUTO_INCREMENT for table `tbl_service_home`
--
ALTER TABLE `tbl_service_home`
  MODIFY `ser_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=7;

--
-- AUTO_INCREMENT for table `tbl_slider`
--
ALTER TABLE `tbl_slider`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=4;

--
-- AUTO_INCREMENT for table `tbl_social_media`
--
ALTER TABLE `tbl_social_media`
  MODIFY `social_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=2;

--
-- AUTO_INCREMENT for table `tbl_stativ_pages`
--
ALTER TABLE `tbl_stativ_pages`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=8;

--
-- AUTO_INCREMENT for table `tbl_subcategory`
--
ALTER TABLE `tbl_subcategory`
  MODIFY `id` int(100) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=40;

--
-- AUTO_INCREMENT for table `tbl_testimonial`
--
ALTER TABLE `tbl_testimonial`
  MODIFY `testi_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=12;

--
-- AUTO_INCREMENT for table `tbl_web_logo`
--
ALTER TABLE `tbl_web_logo`
  MODIFY `logo_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=14;

--
-- AUTO_INCREMENT for table `tbl_why_us`
--
ALTER TABLE `tbl_why_us`
  MODIFY `why_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=2;
COMMIT;

